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CHAPTER I 
INTRODUCTION 
Endocrinology of idiopathic oligospermia 
In spite of increasing knowledge of endocrine mechanisms controlling male reproduc­
tive function1·2 the clinical problem of impaired male fertility is as yet far from solved. 
In marked contrast to the situation in women, distinct endocrine abnormalities causing 
infertility in men are uncommon. If the pituitary fails to secrete gonadotropins inferti­
lity is rarely the presenting feature; delayed puberty or loss of libido and impotence 
are the primary complaints. In most men presenting with oligospermia no diagnosis 
of specific underlying pathophysiology can be made.3 Although obvious endocrine 
deficiencies in peripheral plasma are generally absent, it is by some accepted policy 
to stimulate testicular function hormonally. Treatment is, however, controversial and 
the results disappointing.4 
Idiopathic oligospermia was previously characterized by defective testicular func­
tion without obvious clinical involvement of Leydig cell activity. At present the major 
objective of endocrine investigation in the infertile male is hormone measurement in 
peripheral plasma. A significant impairment of testosterone (T) levels, the major hor­
mone secreted by the testis, is mostly reported to be absent in this group,5 although 
a tendency towards lower Τ levels has been noted in some studies.6 Serum gonadotro­
pin levels were also reported to be in the normal range in most of the infertile men.7 
On the other hand follicle stimulating hormone (FSH) levels (involved with seminifer­
ous tubule function) may be significantly elevated in patients presenting with severe 
oligospermia, with an inverse correlation between sperm count and FSH serum le­
vels.8·9 It is for this reason that FSH measurements are considered to be a useful test 
in the clinical management of male infertility. Elevated FSH levels in men presenting 
with severe oligospermia indicate as a rule untreatable seminiferous tubular damage. 
The measurement of serum T, luteinizing hormone (LH), estradiol (E2) and prolactin 
are considered to be less relevant in routine clinical investigation.10 
The estimation of plasma hormone levels, especially that of LH, may be insufficient­
ly sensitive (due to the pulsatile nature of hormone discharge; see chapter VII) to 
disclose minor abnormalities in the hypothalamic - pituitary - testicular axis. More­
over, peripheral plasma levels may not yield information relevant to the endocrine 
environment of the seminiferous tubules. Endocrine testicular function can further 
be evaluated clinically by hormone estimations in seminal plasma.611 Data obtained 
from these studies, however, are inconsistent and do not relate to hormone concentra­
tions in peripheral plasma nor to the clinical state of oligospermia. 
A compensated state of Leydig cell dysfunction has been suggested in Oligospermie 
men since slightly elevated serum levels of LH were measured together with unchanged 
basal serum levels of gonadal steroids.5 A second method of evaluating Leydig cell 
function in oligospermia is to determine the increase of gonadal steroids following 
administration of human chorionic gonadotropin (hCG) or luteinizing hormone-re­
leasing hormone (LH-RH). hCG induced Τ response has been conflictingly reported 
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as normal5 or impaired12 in Oligospermie patients when compared with normal con­
trols. Recently low-dose LH-RH infusion disclosed a differential Leydig cell response 
between Oligospermie and normal men.13 The delayed Τ response together with the 
relative increase in 17-hydroxyprogesterone (17-OHP) resulting from changes in 
17-OHP/T ratios, as observed in oligospermia, may be interpreted as enzymatic im­
pairment of androgen biosynthesis within the Leydig cells. These data are in agreement 
with in vitro observations in some Oligospermie men in whom gonadotropin serum 
levels were normal despite diminished androgen biosynthesis, as measured in biopsy 
material.14 Because of the apparant importance of high intra-testicular Τ levels for 
spermatogenesis other investigators have tried to obtain information by estimating 
Τ levels in testicular tissue obtained at biopsy. At present these data have not provided 
clinically relevant information, although there is some evidence of impaired Leydig 
cell function in a number of Oligospermie men.15 Hence, preliminary data indicate 
that pathological processes involving the testis do not only disturb seminiferous tubule 
function but may also interfere with inter-tubular steroid production. This further 
emphasizes the necessity of obtaining more, and more accurate information about 
basic regulatory mechanisms involving normal hypothalamic, pituitary, and testicular 
function. Only than will it be possible to define the hormonal lesions underlying im­
paired fertility more precisely. 
The hypothalamic - pituitary - testicular axis 
As early as 1849 Berthold16 demonstrated, by means of transplant experiments in the 
cock, that the testis was hormonally active. Smith (1927)17 suggested that testicular 
function might be under pituitary control, and Harris ( 1948)18 postulated that anterior 
pituitary function was regulated by the brain. This idea was based on the discovery 
of a portal system of blood vessels in the pituitary stalk." It was only in the early 
60s20 that LH-releasing activity was demonstrated in hypothalamic extracts and it be­
came clear that the hypothalamus contains significant amounts of hormones which 
stimulate the release of LH from the pituitary gland. In 1971 two laboratories indepen­
dently purified LH-RH from hundreds of thousands sheep21 and pig22 hypothalami. 
They revealed the structure of LH-RH as a decapeptide and it was subsequently syn-
thetized. The current concept is that endogenous LH-RH is secreted by some hypotha­
lamic nuclei, concentrated in the pituitary stalk and stimulates the anterior pituitary 
to secrete both LH and FSH (for review see Sarker).21 The exact mechanism by which 
LH-RH induces pituitary gonadotropin release is not yet fully understood.24·25 The 
feedback effects of gonadal steroids may modify either hypothalamic secretion, pitui­
tary responsiveness to LH-RH, or both.26 Estimates of radioimmunoassayable LH-
RH levels in the portal blood of the monkey provided evidence for the pulsatile nature 
of hypothalamic LH-RH secretion.27 LH-RH infusion studies in the monkey28 further 
emphasized the physiological significance of intermittent LH-RH secretion for the 
maintenance or reinitiation of pituitary gonadotropin output. Simultaneous measure­
ment of LH-RH levels in the portal circulation together with LH levels in peripheral 
plasma29 demonstrated that pituitary LH is released in pulses as a consequence of 
intermittent LH-RH stimulation (see chapter VII). The intermittent exposure of the 
pituitary to LH-RH probably ensures optimal production and release of gonadotro-
2 
pins by increasing pituitary responsiveness to subsequent LH-RH stimulation.30 This 
so called self-priming effect is at least partly, a consequence of pituitary LH-RH recep­
tor induction by the decapeptide (for review see Clayton and Catt).31 
The gonadotropins (LH and FSH), in turn, influence Leydig cell function and sper­
matogenesis. Within the testis FSH is bound to specific Sertoli cell receptors and stimu­
lates protein synthesis. However, the precise rol of FSH with respect to Sertoli cell 
function and spermatogenesis is still controveгsial.',2',3 LH is bound to Leydig cells 
which in turn produce T. As fas as Sertoli cell products and androgens are concerned 
their exact sites of action on spermatogenesis within the seminiferous tubules remain 
unclear. Factors that regulate intra-testicular steroid production are also incompletely 
defined. LH was long thought to be the only hormone involved in the control of Leydig 
cell steroidogenesis. There is, however, increasing evidence to suggest that the human 
testis is to a large extent controlled locally. Hence, local factors interacts with pituitary 
gonadotropins, either to modulate the action of these hormones on their target cells 
or to alter the responsiveness of the latter to gonadotropic stimulation. Accumulating 
data indicate the existence of a complicated chain of biochemical events involving 
mutual interaction of Sertoli and Leydig cells. Estradiol, mainly derived from intra-
testicular aromatization, modifies Leydig cell Τ synthesis34 and may therefore play 
a local regulatory role on Leydig cell androgen biosynthesis. 
Since pituitary gonadotropins are essential for normal Leydig cell function and LH-
RH was thought to act exclusively on the anterior pituitary gland, the finding that 
large doses of LH-RH inhibit Leydig cell steroidogenesis was unexpected.35 Shortly 
afterwards, the presence of specific Leydig cell LH-RH receptors was described by 
demonstrating the binding of 125I-labelled LH-RH agonists to rat Leydig cell prepara­
tions.36 This observation gave further support to the idea of a direct extra-pituitary 
action of LH-RH on testicular function37 (for a more detailed discussion see chapter 
VII). Under physiological conditions LH-RH of hypothalamic origin cannot be in­
volved in the local regulation of testicular function since the decapeptide never reaches 
the gonads in effective amounts.23 Sertoli cell - Leydig cell interaction may occur via 
an LH-RH like factor secreted within the testis itself.38 However, the origin of the 
LH-RH-like peptide and the significance of the above mentioned observations in the 
rat to human physiology remains controversial.19 
Exogenous LH-RH and pituitary and gonadal function 
Since the introduction in 1972 of synthetic LH-RH as a diagnostic tool in reproductive 
endocrinology, numerous reports of the effects of LH-RH administration on pituitary 
gonadotropin release have appeared. Much information on the physiological mecha­
nisms which regulate the hypothalamic - pituitary system has been accumulated, al­
though investigations in human subjects are limited by the nature of the experimental 
manipulations to be performed. 
Shortly after synthetic LH-RH became available it was shown that the decapeptide 
elicited pituitary release of both LH and FSH40'41 in normal men. In addition, LH-RH 
was administered as a single iv. bolus injection in an attempt to explore further the 
dose-response relationship between exogenous LH-RH and pituitary gonadotropin 
secretion.42-43 Pituitary LH output appeared to be more sensitive to LH-RH stimula-
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tion, occurred faster and in greater amounts than FSH. Beside the magnitude of the 
bolus of LH-RH, pituitary LH response was influenced by prior LH-RH exposure 
as well. Hence, LH-RH sensitizes the gonadotrops to subsequent LH-RH mediated 
gonadotropin release. This phenomenon has only been proven in women in the high-
estrogen phases of the menstrual cycle.44 Both de Kretser et al.45 and Bremner and 
Paulsen46 gave LH-RH by continuous infusion, to study pituitary gonadotropin re-
lease and synthesis patterns as a function of time. A biphasic response pattern was 
noted for LH together with a gradual, progressive increase for FSH. Both continuous 
infusion and identical pulses of LH-RH indicated two phases of response of LH; an 
acute response, thought to represent a readily releasable pool (storage) of hormone, 
and an increased response which becomes apparent after the initial exposure to LH-
RH, i.e. the self-priming or self-potentiating effect of LH-RH. In vitro studies using 
rat pituitary cells47-48 provided further evidence for the idea that new protein synthesis 
was necessary for subsequent LH-RH-induced LH synthesis. This increased LH re-
sponse was thought to reflect primarily the positive feedback action of circulating 
E2 on the anterior pituitary gland. Prolonged LH-RH infusion induces pituitary down-
regulation with diminished gonadotropin output both in animal studies using isolated 
pituitary glands49 and in man50. This desensitization is probably caused by reduction 
in the number of available pituitary LH-RH receptors,31 although a post receptor 
mechanism may also be involved.51 
Infusion studies in the monkey conclusively demonstrated the physiological signifi-
cance of the pulsatile nature of LH-RH secretion; only intermittent LH-RH adminis-
tration is capable of reinitiating sustained pituitary gonadotropin release in animals 
whose endogenous LH-RH secretion has been abolished.28 Continuous infusion has 
no effect. More recently the LH-RH pulse-dose and pulse-frequency for optimal pitui-
tary stimulation has been accurately defined.52 This development has been of great 
clinical interest and in the last few years intensive investigations in all species, including 
man, have been focussed on the pulsatile nature of hypothalamic LH-RH discharge 
in the control of pituitary and gonadal function. Intermittent LH-RH administration 
has been applied extensively to patients with different forms of hypogonadotropic 
hypogonadism, delayed puberty and cryptorchism. Its use in the induction of ovula-
tion in hypogonadotropic amenorrheic women has been particulary successful and 
enjoys widespread use in the treatment of infertility due to anovulation (for review 
see Ory53 and Yen54). 
Aim of the studies 
The need for a better understanding of the basic endocrine mechanisms which regulate 
pituitary and gonadal function in the male has already been emphasized. The main 
objective of this thesis was to determine the effects of exogenous LH-RH administra-
tion on pituitary and testicular response patterns in healthy male volunteers. This 
type of investigation presents a number of problems in the human due, for example, 
to the intact feedback mechanism stimulated by continuously changing gonadotropin 
and testicular steroid levels. Nevertheless, it is thought that this approach offers the 
best opportunity for testing new ideas on basic reproductive endocrinology, obtained 
from in vivo and in vitro animal studies in man (for discussion see chapter VII). 
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As mentioned previously, the priming effect of intermittent LH-RH administration 
is defined as an enhanced gonadotropin secretion following subsequent LH-RH stimu-
lation. That this priming effect was of fundamental importance was later emphasized 
by the discovery of the necessity for intermittent LH-RH exposure to prolonged pitui-
tary function. This criterion of normal pituitary function in the adult female, however, 
could not be confirmed in the male.55 We have searched for a more sensitive method 
of determining the possible occurrence of this priming phenomenon in the male 
(chapter II and III), by using different types of frequency-, and amplitude-modulated 
intermittent LH-RH administration and by making use of an integrated instead of 
momentaneous blood sampling technique (this subject will be discussed in detail in 
chapter VII). We also compared the absolute increase of LH and FSH levels during 
the entire test period at different LH-RH doses and frequency intervals, instead of 
comparing the amount of gonadotropin release following each subsequent LH-RH 
stimulation. 
Recently there has been much speculation in the literature about the possible direct 
effects of LH-RH on testicular function. This mechanism may be relevant to the intra-
testicular control of Leydig cell function. Since different modes and doses of exogenous 
LH-RH did provoke pituitary gonadotropin release of a comparable magnitude 
(chapter III), we considered that it might also be useful to investigate Leydig cell steroid 
production. If a differential Leydig cell response could be determined, this might indi-
cate direct testicular effects of exogenous LH-RH. Results from this study are pre-
sented in chapter IV. 
In view of the possibility of the patient group presenting with idiopathic oligosper-
mia including individuals with minor abnormalities in Leydig cell function, and the 
lack of criteria for identifying these patients, we thought it would be useful to investi-
gate the influence of pulsatile LH-RH therapy on hormonal parameters and sperm 
qualities in this group. LH-RH was administered in a regimen which had proved to 
be successful in hypogonadotropic men and women. Data on the possible changes 
in sperm analyses and hormone levels during and following LH-RH therapy are pre-
sented in chapter V. The absence of any detectable increase in hormone levels in peri-
pheral plasma raised many questions about the long-term use of the sc. route of admin-
istration. Furthermore, the pulse doses of LH-RH used may have been insufficient. 
The literature provided insufficient information to determine the preferred dose and 
route of administration. 
Recently the lack of sufficient data on basic LH-RH pharmacokinetics has led to 
considerable controversy about the most appropriate dose and route of exogenous 
LH-RH in pulsatile LH-RH therapy. The availability of reliable RIA techniques for 
quantifying LH-RH plasma levels prompted us to determine LH-RH levels following 
low-dose LH-RH injections, and to compare these values with estimates of endoge-
nous LH-RH release. In addition, pituitary gonadotropin response patterns were de-
termined in an attempt to establish the optimal dose and route of administration of 
LH-RH (chapter VI). 
In chapter VII (general discussion) animal and human studies with special attention 
payed to physiological mechanisms which regulate pituitary function, are discussed. 
Animal studies were classified, according to approach, as follows: 1. Studies perform-
ing direct LH-RH measurements in the portal circulation, 2. In vitro studies using 
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pituitary glands or isolated pituitary cells, 3 Studies using exogenous LH-RH adminis­
tration in hypothalamic lesioned animals. Human studies were divided into: 1. Studies 
to investigate the patterns of endogenous LH secretion in peripheral plasma, and 2. 
Studies using exogenous LH-RH administration in adult men to investigate the pattern 
of pituitary gonadotropin secretion. Attention was focused on published data which 
were of special relevance to the studies presented in this thesis Our own work, using 
exogenous LH-RH in the adult male, is further discussed in the light of recent findings 
concerning pharmacokinetic aspects of LH-RH administration This may lead to new 
ideas on prefered study protocols, and some suggestions for further investigation are 
ofTered 
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CHAPTER II 
THE EFFECT OF PULSATILE AND CONTINUOUS 
INTRAVENOUS LUTEINIZING HORMONE-
RELEASING HORMONE ADMINISTRATION ON 
PITUITARY LUTEINIZING HORMONE AND 
FOLLICLE-STIMULATING HORMONE RELEASE IN 
NORMAL MEN 
BCJM Hauser, JMJ Dony, WH Doesburg. R Rolland 
(Published in Fertility and Sterility 39:695,1983) 
Abstract 
In 14 healthy, potentially fertile men, pituitary gonadotropin responses were studied 
under standardized conditions. LH-RH was given as a continuous infusion of 1 ug/ 
minute for 4 hours or in a pulsatile fashion with 20 ug as an intravenous bolus at 
intervals of 20 minutes for 4 hours. Blood was collected continuously by means of 
an integrated sampling technique. 
The mean serum LH concentration showed an oscillating pattern around a plateau 
level reached within 45 minutes during continuous LH-RH administration. During 
pulsatile infusion, an identical pattern for the first 45 minutes was observed with, there-
after, a continuous increase from 105 minutes until the end of the infusion. The mean 
increase in the serum LH level during pulsatile administration was significantly higher 
(P = 0.00001) than the mean increase seen during continuous infusion. The FSH con-
centration revealed a gradual progressive increase after both methods of stimulation, 
without a significant difference in the mean increase between the two types of adminis-
tration. 
This study demonstrated the existence of a self-priming effect of LH after pulsatile 
LH-RH administration in the man like that in the woman. 
Introduction 
Direct measurement of LH-RH in the portal circulation of ovariectomized monkeys1·2 
shows that LH-RH is secreted by the hypothalamus in a pulsatile fashion. One may 
assume that the pulsatile pattern of gonadotropin secretion in man1 is not only an 
intrinsic effect of the pituitary but also the result of changing LH-RH concentrations 
in the portal circulation of the pituitary stalk. 
The influence of continuous intravenous LH-RH administration on the pituitary 
LH and FSH responses in the normal man has been investigated by several authors.4 B 
This method of stimulation seems useful for the examination of the pituitary's capacity 
to release stored gonadotropins. For the examination of the pituitary's capacity to 
synthesize gonadotropins, a pulsatile method of stimulation may give more informa-
tion. Repeated LH-RH administration, with equal dosages, to animals both in vivo9 
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and in vitro 1 0 1 2 showed an increasing response for LH (self-priming effect). Increasing 
LH synthesis must be responsible for this phenomenon. In women this priming effect 
has been convincingly demonstrated in the late follicular phase of the cycle, for LH.13·14 
In men no priming effect was seen after repeated administration of 10 or 150 ug 
LH-RH as an intravenous bolus with an interval of 2 hours.15 
The aim of the present report was to compare continuous and pulsatile intravenous 
LH-RH administration in healthy, potentially fertile men under standardized condi­
tions in an attempt to explore further the mechanism by which release of gonadotro­
pins is regulated in men. 
Materials and methods 
Fourteen male volunteers, 23 to 43 years of age, agreed to participate in the study 
after informed consent. All subjects were healthy men with normal body weight for 
height. No endocrinologie or andrologic problems were present. The sperm analysis 
of all volunteers showed a concentration > 20 χ IO6 sperm/ml and < 40% abnormal 
forms. In all analyses the sperm motility was reported as good. 
According to their participation in the two types of LH-RH administration, the 
group of 14 men was divided as follows: 3 men participated in both the continuous 
and the pulsatile experiments; 6 men participated only in the continuous LH-RH infu­
sion study; and 5 others participated only in the experiment with the pulsatile LH-RH 
administration. 
Continuous infusion 
Synthetic LH-RH (Hoechst Holland N. V., The Netherlands) was administered to nine 
men by constant intravenous infusion (Harvard pump) for 4 hours through an indwell­
ing catheter in one arm. The amount of LH-RH administered was chosen as 1 ug/ 
minute. This is in agreement with the dosage used by several other authors.5·6 
Pulsatile administration 
Synthetic LH-RH was administered to eight men as 20 ug intravenous bolus doses 
at intervals of 20 minutes for 4 hours through a butterfly needle in one arm. The 
total doses administered in both tests were equal (240 ug). All tests took place between 
5:00 P.M. and 10:00 P.M. The time elapse between the continuous and the pulsatile 
experiment was 4 months. 
Sampling procedure 
Blood was obtained by a constant withdrawal pump through a heparin-coated Kow-
arski catheter,16 which was introduced in an antecubutal vein of the arm where no 
LH-RH was administered. Blood was collected at 15-minutes intervals (10 ml at each 
time) for 5 hours. The first two samples (—15 and 0 minutes) gave baseline values, 
and the last two samples were taken at 15 and 30 minutes after the 4-hour test period 
had stopped. After centrifugation, the serum was stored at — 20 0 C until assayed. 
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All samples from one candidate were measured in the same assay run. Serum LH 
and FSH were measured with the use of a double-antibody radioimmunoassay tech-
nique. This procedure has recently been described elsewhere." LH is expressed in IU/1 
(Medical Research Counsil (MCR) 68/40) as is FSH (MCR 69/104). The coefficients 
of variation for the wi thin-assay and between-assay variability of means of duplicate 
measurements are 8.6% and 16.3% for LH, and 8.1% and 13.5% for FSH. 
Statistical analysis 
The variable of interest, for the statistical comparison between the effects of the type 
of LH-RH administration, was chosen to be the averaged serum level in the 4.5-hour 
test period minus the averaged baseline value, which is defined as the individual in-
crease in the serum level. Since the increase seemed to be correlated with the baseline 
value, a correction had to take place for the differences in baseline values at the com-
parison of the effects of pulsatile and continuous administration. In this respect, an 
analysis of covariance was considered to be the appropriate technique18 for estimation 
of the difference in mean increase of the serum level between the two types of adminis-
tration. Due to the design of the experiment (partially incomplete data) estimates for 
this difference were obtained separately from the pairwise (men who participated in 
both tests) and the remaining two-sample data. Afterwards, both estimates were linear-
ly combined (Table 1). This ultimate estimate of the difference in mean increase after 
continuous and pulsatile administration was tested for its significance. 
Results 
An unexpected finding is the difference in mean gonadotropin baseline values of the 
groups tested with continuous or pulsatile LH-RH administration (6.9 + 1.1 and 
10.1 ± 1.7 IU/1 (mean + SEM) for LH, and 2.1 + 0.3 and 3.8 ± 0.3 IU/1 for FSH, 
respectively). 
Gonadotropin responses after continuous LH-RH administration 
The pattern of LH response can be described as follows (Fig. 1). We observed an 
initial increase, with a peak reached within 45 minutes after starting the infusion (mean 
increase, 23.8 + 4.9 IU/1). After the initial increase there were insignificant changes 
around a plateau level. FSH levels revealed a gradual progressive increase during the 
infusion, with a maximum at the end of the infusion (Fig. 2). The maximum levels 
obtained were, related to the baseline value, much lower than for LH (mean increase 
3.8 ±0 .6 IU/1). 
Gonadotropin responses after pulsatile LH-RH administration 
LH showed an initial increase, identical to the response after continuous stimulation 
(Fig. 1), with a first peak reached within 30 to 45 minutes (mean increase 33.4 + 
2.5 IU/1). This was followed by a short period of concentrations similar to the initial 
peak and thereafter increasing mean serum levels from 105 minutes up to the end 
11 
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Table 1 Comparison of Continuous and Pulsatile LH-RH Administration 
After Correction for Differences in Baseline Values'" 
LH FSH 
Two-sample 
Continuous (η - 6) 
Pulsatile (n = 5) 
Pairwise (n = 3) 
Weighted linear combination 
11 8 ± 2 9 
7 2 ± 2 8 
9 4 ± 2 0 
Ρ - 0 0 0 0 0 1 
0 45
 =
 0 8 b 
-0 06 ± 0 7 b 
ОЗ + ОТ' 
Ρ - 0 6 5 
"Values are the mean ± SEM 
Estimates obtained with an analysis of covanance technique adapted to each 
ofthe data types (two sample and pairwise) 
ЧГ й] + SEM| and 02 ± SEM2 are the respective estimate and its standard 
error for the two sample pairwise data, then the ultimate estimate is obtained 
asW|0| + W202, with wi + W2 = 1 
w, = I/SEM 2 ! , + 
SFM 2, SEM 2 2 
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of the administration (mean increase 44.6 ± 4.7 IU/1). The mean increase in LH con­
centration over the test period was significantly higher after pulsatile than after contin­
uous administration (P = 0.00001) (Table 1). We observed a gradual progressive in­
crease for the mean FSH concentration after pulsatile and after continuous stimulation 
(mean increase 8.0 ± 1.3 IU/1) (Fig. 2). There was no significant difference between 
the mean FSH increase after either type of administration (Table 1). 
Discussion 
It was difficult to compare the data described by several authors concerning the contin­
uous LH-RH infusion in men. The reasons were the small number of investigated 
men in some publications, the difference in LH-RH dosage, the interval between blood 
collections, and determination of the basal level. The great response variation between 
different publications and between candidates from the same group was a remarkable 
phenomenon in many studies. 
After a pulsatile administration, we observed an initial mean peak level for LH 
reached within 30 to 45 minutes with, thereafter, progressively increasing mean levels 
until the end of the infusion. This pattern is clearly different from the response ob­
served after continuous administration where, after the initial peak, an oscillating pat­
tern around a plateau was seen. The LH response in our study only partially agreed 
with previously described data, in spite of our greater and well-defined research group 
and the use of an integrated sampling technique. Other causes can be the difference 
in LH-RH dosage and the difference in time of day of the test. The gradual progressive 
increase for mean FSH concentration did agree with the data described in the litera­
ture. 
It is likely that biological and assay variations were the main but not the only causes 
of the differences in baseline gonadotropin values (FSH, Ρ = 0.001; LH, Ρ = 0.15) 
(Table 1, footnotes). An additional explanation for the differences in baseline values 
of the groups for continuous and pulsatile administration has not been found. In both 
groups the sperm analyses were equal with a total sperm count of 267 + 54 (mean 
+ SEM) in the group that received continuous administration and of 228 + 39 in 
the group that received pulsatile LH-RH administration. Also, mean Τ concentrations 
were similar (316 ± 24 and 287 ± 27 ng/dl, respectively). 
The self-priming effect for LH has been described as an increasing response for 
LH after repeated LH-RH administration in equal dosages. We studied the effect of 
continuous and pulsatile stimulation, in equal dosages, by comparing the averaged 
serum levels of LH and FSH during the 4.5-hour test period, after correction for differ­
ences in baseline values between the two groups. The average serum LH level after 
pulsatile administration was significantly higher (Table 1 ) than after continuous ad­
ministration. An increasing response for LH after pulsatile LH-RH administration 
must be responsible for the described difference. We observed no significant difference 
in the mean FSH increase after both methods of stimulation. This difference indirectly 
demonstrates the existence of a priming effect for LH after repetitive LH-RH adminis­
tration with a short time interval. The existence of a priming effect for LH in women 
in the late follicular phase, and the absence of this phenomenon in the early follicular 
phase," suggests that the gonads, through its steroid feedback, may influence this 
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priming effect as well. The immediate changes in the steroid concentrations during 
the infusion tests should therefore also be investigated. However, in vitro perfusion 
tests with rat pituitaries" also showed this self-priming effect for LH, indicating that 
the influence of gonadal steroids can only be a modulating one on an already existing 
mechanism. 
In the presented study, in the pulsatile group, an interval of 20 minutes was chosen 
between each pulse. LH-RH has a very short half-life of approximately 5 minutes.20 
Therefore, the observed differences in LH responses were assumed to be due to the 
changing LH-RH concentrations brought on by the pulsatile administration. It ap­
pears that the frequency of pulsatile LH-RH release in women is between 60 and 120 
minutes.21 If this also holds true in men, further studies with longer intervals of pulsatile 
LH-RH administration should confirm the observed results. 
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CHAPTER III 
PITUITARY GONADOTROPIN RESPONSES TO 
DIFFERENT MODES AND DOSES OF INTRA-
VENOUS LUTEINIZING HORMONE-RELEASING 
HORMONE ADMINISTRATION IN NORMAL MEN 
BCJM Fauser, R Rolland, JMJ Dony, WH Doesburg, CMG Thomas 
(Published in Fertility and Sterility 41:748,1984) 
Abstract 
In 22 potentially fertile men, pituitary gonadotropin secretion was investigated by 
intravenous LH-RH administration. LH-RH was administered continuously (1 ug/ 
minute) and in a pulsatile fashion (20 ug at 20-minute intervals, 20 ug at 60-minute 
intervals, and 60 ug at 60-minute intervals), for 3 hours, under standardized condi-
tions. Blood was collected continuously by means of an integrated sampling technique. 
The mean serum LH concentration after any type of pulsatile administration rose 
significantly more than after continuous LH-RH administration. The mean increase 
in LH after pulsatile LH-RH administration with a 60 ug dose and 60-minute intervals 
was significantly greater than after pulsatile administration with a 20 ug dose and 
20- or 60-minute intervals. No differences were observed in FSH responses after any 
type of LH-RH administration. 
These data confirm the existence of a self-priming effect for LH in the men, and 
maximum pituitary stimulation, within the dosage range tested, is reached after pulsa-
tile LH-RH stimulation with an interval of 60 minutes. 
Introduction 
Previously changing concentrations of LH-RH were observed in the portal circulation 
of the monkey.1·2 Indirectly investigators have tried to obtain more information con-
cerning the physiological pattern of endogenous LH-RH secretion in the human by 
comparing induced LH secretion and spontaneous, pulsatile LH release.3 Great inter-
individual differences in LH-RH levels have been demonstrated in blood samples col-
lected from the human pituitary gland,4 and in human peripheral plasma a pulsatile 
pattern of LH-RH was discovered with episodes of LH-RH rises every 60 minutes.5 
Initial LH-RH exposure induces increasing LH responses after subsequent adminis-
tration. This self-priming effect was first demonstrated in the rat,6-7 and later confirmed 
in women in the late follicular phase.8·9 In these studies the dependency on gonadal 
steroids was clearly demonstrated. The priming effect depends on the synthesis of 
new proteins10·11 and may be partially explained by induction of pituitary LH-RH 
receptors.12 The physiological significance of pulsatile LH-RH release was convincing-
ly demonstrated by Belchetz et al.11 They showed that in ovariectomized monkeys 
bearing hypothalamic lesions, continuous LH-RH administration failed, whereas pul-
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salile administration did reestablish pituitary gonadotropin secretion. In the rhesus 
monkey the accurate frequency and amplitude of pulsatile LH-RH administration 
needed for maximum pituitary stimulation has been described.1'1 These findings dem­
onstrate that the pattern of LH-RH stimulation is of primary importance in the control 
of pituitary activity. Recently, encouraging results were reported concerning the thera­
peutical use of pulsatile LH-RH administration in men with hypogonadotropic hypo­
gonadism.15 
Although Lasley and colleagues16 failed to demonstrate a self-priming effect in the 
men, our previous results17 indirectly did confirm the existance of such a phenomenon. 
The purpose of the present study is to compare the influence of pulsatile LH-RH 
administration, with different doses and time intervals, on pituitary gonadotropin se­
cretion in men, to establish more precise the pituitary response patterns in relation 
to dose and pulse frequency changes. 
Materials and methods 
Twenty-two healthy men between 23 and 43 years of age volunteered for this study 
and gave informed consent. No endocrinologie or andrologic problems were present. 
The semen analyses in all subjects were normal, with a sperm count > 20 χ 106/ml 
and < 40% abnormal forms. In all analyses the sperm motility was reported as good. 
All studies took place between 5:00 P.M. and 10:00 P.M. The time interval between 
different experiments in the same subjects was at least one month. 
Different types of LH-RH administration 
Continuous infusion: Synthetic LH-RH (Hoechst Holland N.V., Amsterdam, The 
Netherlands) was administered to nine men by constant intravenous infusion (Harvard 
pump) for 3 hours through an indwelling catheter in one arm. The amount of LH-RH 
was chosen as 1 ug/minute (further mentioned as C(1,I)). 
Pulsatile administration: Synthetic LH-RH was administered through venipuncture 
in one arm to eight men as a 20 ug bolus dose at 20-minute intervals (P(20,20)); to 
eight men as a 20 ug dose at 60-minute intervals (P(20,60)) and to eight men as a 
60 ug dose at 60-minute intervals (P(60,60)). 
The total dose of administered LH-RH was equal (180 ug) in three of four tests. 
In the P(20,60) experiment the total amount of LH-RH administered during the test 
period was 60 ug. 
According to their participation in the studies with different types of LH-RH admin­
istration, the group of 22 men was divided as follows: four men participated in the 
C(l,l), the P(20,60), and the P(60,60) experiments. Two of these men participated 
also in the P(20,20) experiment. Four men participated only in the C(l,l), five men 
only in the P(20,20), four men only in the P(20,60), and four men only in the P(60,60) 
experiments. One man participated in the C(l,l) and in the P(20,20) experiments. 
There was no selection in the participation of the candidates for the different tests. 
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Sampling procedure 
Blood was obtained by a constant withdrawal pump through a heparin-coated Kow-
arski catheter,18 which was introduced in an antecubital vein of the arm where no 
LH-RH was administered. Blood was collected in 15-minute aliquots (10 ml each) 
for 3.5 hours. The first two samples (—15,0) give baseline values. After centrifugation 
the serum was stored at — 20 0C until assayed. Serum LH and FSH levels were deter-
mined by specific radioimmunoassay.17 LH is expressed in IU/1 (Medical Research 
Counsel (MRC) 68/40), as is FSH (MRC 69/104). The coefficients of variation for 
the within-assay and between-assay variability of means of duplicate measurements 
are 8.6% and 16.3% for LH and 8.1% and 13.5% for FSH. All samples from one candi-
date were measured in the same assay run. 
Statistical analysis 
The variable of interest, for the statistical comparison between the effects of the dif-
ferent types of LH-RH administration, was chosen to be the average serum level in 
the 3-hour test period (E = experimental concentration) minus the averaged baseline 
value (B), which is defined as the individual increase in the serum level. Since the 
increase seemed to be correlated with the baseline value, a correction had to take 
place for the difference in baseline values at the comparison of the effects of different 
types of LH-RH administration. In this respect, an analysis of covariance was consid-
ered to be the appropriate technique19 to estimate the difference in mean increase of 
the serum levels after different types of LH-RH administration. Due to the design 
of the experiment (partially incomplete data), estimates for the difference in mean 
increase were obtained separately from the pairwise (men who participated in both 
tests) and the two-sample data. Afterwards, both estimates were linearly combined 
as previously described.17 This ultimate estimate of the difference in mean increase 
after different types of LH-RH administration was tested for its significance (Tables 
1 and 2). 
Results 
Mean gonadotropin baseline values differed among the investigated groups tested with 
different types of LH-RH administration from 7.2 ± 1.0 until 15.1 ± 2.0 IU/1 (mean 
± SEM) for LH and 2.1 ± 0.3 until 4.7 ± 0.9 IU/1 for FSH. 
LH responses 
No evident differences were observed in LH response patterns in each group tested 
with different types of LH-RH administration. All responses showed a quick increase 
with maximum levels at 30 to 45 minutes after the start of the administration. After 
this increase in the C( 1,1) and the P(20,20) experiments, LH levels more or less pla-
teaued until the end of the test period. In the pulsatile experiments with 60-minute 
intervals (P(20,60)) and P(60,60)) an oscillating pattern was observed, with rises after 
each bolus dose (Fig. 1). In the 3-hour test period each type of pulsatile LH-RH admin-
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Figure 2 
FSH responses (mean + SEMHodifferenttypesof LH-RH 
istration caused higher responses for LH, after correction for differences in baseline 
values, than after continuous administration (Table 1). This difference is significant 
(P < 0.001) for the comparison of the P(60,60) and P(20,20) versus the C(l,l) experi­
ment. There is strong evidence (P = 0.07) for a higher pituitary response for LH after 
the P(20,60) compared with the C(l,l) experiment, although the total amount of LH-
RH administered during the P(20,60) experiment is a third of the total amount admin­
istered during the continuous infusion. Differences were also noticed in mutual com­
parison of the different types of pulsatile LH-RH administration (Table 2). The in­
crease in mean LH concentration in the P(60,60) experiment is significantly higher 
than in the P(20,20) (P = 0.005) and in the P(20,60) (P = 0.01) experiments. No 
significant difference was observed in mean LH responses during the last two men­
tioned types of LH-RH administration. 
FSH responses 
In general, FSH responses were much smaller than the responses for LH. The maxi­
mum mean increase for FSH was 8.7 + 3.4 IU/'l reached at 165 minutes after the 
start of the administration (P(60,60)), and for LH, 52.0 ± 3.3 IU/1 reached at 150 
minutes (P(60,60) as well). All FSH response patterns were generally the same after 
any type of LH-RH administration. Especially after the C(l,l), the P(20,20) and the 
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P(20,60) experiments, a small but progressive increase was noticed In the P(60,60) 
experiment an oscillating pattern was observed in mean FSH serum levels, with rises 
after each bolus dose There was a large variability in baseline and experimental FSH 
levels between the participants of the P(60,60) experiment, resulting in large SEM 
values (Fig 2) No significant difference was observed in the mean increase in the 
FSH levels after each type of LH-RH administration (Tables 1 and 2) 
Discussion 
In previous studies89 the self-priming effect after LH-RH administration was investi-
gated in the human by comparing the magnitude of each increase in pituitary gonado-
tropin release after repeated administration of LH-RH Pulsatile administration of 
a 10 or 150 ug dose at 2-hour intervals to six eugonadal men did not result in increasing 
responses for LH after each LH-RH administration l(> The administration of estradiol 
and clomiphene suggested both a negative and a positive effect of estrogens in the 
regulation of gonadotropin secretion in the men In women the self-priming effect 
was confirmed by the same research group, and the dependency on gonadal steroids 
was convincingly demonstrated 89 This pruning effect is most evident in the presence 
of high estradiol levels. In our opinion, a more sensitive way to investigate the self-
pnming effect after different types of LH-RH administration is to compare gonadotro-
pin patterns during the test period, instead of comparing the amount of gonadotropin 
release after each subsequent LH-RH administration Also, to investigate in a more 
sensitive way, we have chosen to analyze the absolute increase in mean serum levels 
of LH and FSH instead of comparing differences m percent increase If the same total 
amount of LH-RH is given under standardized conditions, it is, by this means, possible 
to observe the influence of different types of LH-RH administration on pituitary gona-
dotropin release 
The mentioned differences in gonadotropin baseline values between the investigated 
groups are in agreement with previously described observations.17 The described pat-
tern of LH response after continuous LH-RH administration (see Results) does not 
agree with the data described in the literature 20 This was also previously mentioned. 
Any type of pulsatile LH-RH administration gives higher mean LH serum levels dur-
ing the 3-hour test period, compared with continuous administration (Table 1) This 
higher response is likely to be caused by increased LH synthesis In the light of recent 
receptor studies, it is accepted that the self-pnming effect for LH is, at least partially, 
caused by pituitary LH-RH receptor induction 12 This is a process of autoregulation 
Mutual comparison between pulsatile LH-RH administration shows a greater increase 
in LH after the P(60,60) than after the P(20,20) or the P(20,60) experiments (Table 
2) No differences are observed in mean FSH levels after any type of LH-RH adminis-
tration The observed pattern of progressively increasing mean FSH levels is in agree-
ment with the data described in the literature 20 All experiments took place at the 
same time of day This was planned to exclude possible daily variations in pituitary 
gonadotropin response as described by Schwarzstein et al21 The chosen interval of 
60 minutes for repeated LH-RH administration is in agreement with the observed 
pattern of endogenous LH-RH in peripheral plasma, with episodes of rising concentra-
tions every 60 minutes 5 Because of the very short half-life of LH-RH22 the pulsatile 
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Table 1 CompansonofConlinuousand Different fypesof Pulsatile Ι H RH Administration (Mean ± SbMC 
LH 
Two sample 
Pulsatile 
Continuous 
Pairwise 
Weighted linear combination 
bSH 
Two sample 
Pulsatile 
Continuous 
Pairwise 
Weighted linear combination 
P(20,M)-C(I,1) 
n = 5 
n = 6 
n - 3 
n - 5 
n - 6 
n = 3 
11 2 ± 2 8 
6 7 + 3 1 
9 2 + 21 
u = 44l 
P < 0 001 
0 38 + 0 80 
0 17 + 233 
0 36 + 0 76 
u = 0 48 
P = 064 
P(20,60)-C(1,I) 
n = 4 
n = 5 
n = 4 
n = 4 
n = 5 
n = 4 
25 2 ± 23 8 
32 + 09 
3 2 ± 0 9 b 
t2 = 3 55e 
Ρ = 0 07 
1 73 t 2 02 
0 39 + 0 36 
0 43 + 0 35 b 
t2 = 1 23 
/' = 0 34 
P(60,60)-C(l,l) 
n - 4 
n = 5 
n = 4 
n - 4 
n = 5 
n = 4 
23 6 ± 3 1 
1 0 5 ± 3 0 
168 + 1 09 
u - 7 6 4 
p<om 
0 38 ± 1 09 
0 11 + 0 43 
0 1 5 + 0 4 0 
u = 0 38 
P = 01\ 
'Estimates obtained with an analysis of covanance technique, adapted to each of the data types 
No additional information from the two-sample data 
ct2. Student s ι tesi with 2 degrees of freedom 
Table 2 Mutual Comparison of Three Different Types of Pulsatile LH RH Administration (Mean + SEM)" 
LH 
Two sample 
Pairwise 
Weighted linear combination 
FSH 
Two sample 
Pairwise 
Weighted linear con ibmation 
P(60,60)-P(20,20) 
ll) = 6 
Пт = 6 
n = 2 c 
ni = 6 
П2 — 6 
n = 2 c 
0 9 + 2 4 b 
9 0 ± 2 4 
t 9 = 3 69
d 
Ρ - 0 005 
0 2 1 + 0 7 6 
0 21 ± 0 76 
t9 = 028 
/» = 076 
P(20,20)-P(20,60) 
П! - 6 
П2 = 6 
n = 2 2 
П| - 6 
П2 = 6 
n = 2 c 
20 + 82 
20 + 82 
4 - 0 2 4 
/' = 081 
081 + 1 17 
-081 + 1 17 
tç = 0 69 
/• = 051 
P(60,60)-P(20,60) 
n 1 = 4 
n-, = 5 
n = 4 
n l = 4 
П 2 - 4 
n = 4 
15 + 119 
И 3 t 3 9 
1 0 3 + 3 7 
u = 278 
P - 0 0 1 
Ю 95 + 1 86 
0 38 ± 0 92 
0 12 ± 0 82 
u = 015 
/> = 088 
abstimates obtained with an analysis of covanance technique, adapted to each of the data types 
η |, number of participants in the first mentioned type of administration 
T^Iumber of participants too small for statistical estimation of the difference in mean increase 
"tg Student's t test with 9 degrees of freedom 
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administration with 20-minute intervals gives constantly changing LH-RH levels. The 
test period of 3 hours used in this study was relatively short. Our previous study17 
concerning mean gonadotropin responses after 2 types of LH-RH administration 
(P(20,20) and C( 1,1 )) using a test period of 4.5-hours gave rather the same information. 
In both test periods the estimated difference in LH response after the two types of 
administration is the same (9.4 ± 2.0 for the 4.5-hour test period, and 9.2 ± 2.1 
for the 3-hour test period). 
In studies concerning the self-priming effect in women8·9 the dependency on gonadal 
steroids was obvious. However, this self-priming effect was also observed in studies 
with in vitro perfusion techniques in rat anterior hemipituitaries.7 Hence, the gonadal 
steroids cannot be of primary importance for this phenomenon. Analyzing testoster­
one and oestradiol in the subjects in our study has until so far given no indication 
of an important effect on pituitary responsiveness to LH-RH (unpublished data21). 
After the discovery of the physiologic significance of pulsatile LH-RH administra­
tion in the rhesus monkey,'3 the accurate frequency and amplitude of pulsatile LH-RH 
administration for maximum pituitary stimulation was described.14 In the present re­
port pituitary gonadotropin response was investigated after repeated LH-RH stimula­
tion, with different doses and time intervals, in healthy normal men. An attempt was 
made to elucidate the physiological significance of pulsatile pituitary stimulation in 
the men. One must be careful in speculations concerning the physiological significance 
of the observed results because the possibility of mutual influence between endogenous 
and administered LH-RH cannot be excluded. 
It is concluded that, within the limits of the used experimental design (frequency 
and dose of pulsatile LH-RH administration), maximum pituitary stimulation in men 
is reached for LH after pulsatile LH-RH administration with 60-minute intervals. The 
magnitude of LH release is, beside the interval of LH-RH administration, also related 
to the amount of LH-RH administered. 
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CHAPTER IV 
TESTICULAR STEROID RESPONSE TO 
CONTINUOUS AND PULSATILE INTRAVENOUS 
LUTEINIZING HORMONE-RELEASING HORMONE 
ADMINISTRATION IN NORMAL MEN 
BCJM Fauser, AGH Smals, R Rolland, JMJ Dony, WH Doesburg, CMG Thomas 
(Submitted for publication) 
Abstract 
In 18 healthy normal men Leydig cell response was examined following intravenous 
LH-RH administration under standardized conditions. The same total amount of LH-
RH was administered for 3 hours both in a continuous (1 ug/min; C(l,l)) and in a 
pulsatile fashion, by giving a 20 ug dose at 20-minute intervals, P(20,20), and a 60 
ug dose at 60-minute intervals, P(60,60). Blood was collected continuously over a peri­
od of 3 hours 15 minutes using an integrated sampling technique. 
Following the different modes of LH-RH administration which all caused 3 - 4 
fold elevations of the mean endogenous LH concentrations and 1.7-2 fold elevations 
of the mean FSH serum levels, an overt increase of the mean Τ levels was noticed 
up to 1.5 χ the baseline value. No difference was observed in the total amount of 
Τ release among the investigated groups. The patterns of the Τ response, however, 
clearly differed from one another with a rapid increase, a nadir at 60 minutes and 
a second rise and plateau afterwards during the C(l ,1) and the P(20,20) LH-RH admin­
istration, and a delayed but persistent Τ increase in the P(60,60) experiment. The mean 
17-OHP concentrations demonstrated a similar course to Τ in the P(60,60) experiment, 
while significant increases of the E2 levels were never observed in all three experiments. 
In view of the comparable LH and FSH increments in response to LH-RH adminis­
tration in either experiment the differences in Τ responses may be explained by assum­
ing a direct effect of LH-RH on Leydig cell steroidogenesis in the men. 
Introduction 
Steroidogenesis in the human testis is under primary control of LH-RH mediated 
pituitary LH, although not all spontaneous LH pulses are followed by corresponding 
changes in Τ levels in peripheral plasma.1 It was therefore suggested that in addition 
to LH still other factors are involved in controlling Τ secretion and direct effects of 
LH-RH itself have also been considered.2 It is known that FSH, on the other hand, 
exerts a synergistic role with LH in the regulation of Τ secretion.3 
The present study was designed firstly to examine short term Leydig cell responses 
following (continuous and pulsatile) LH-RH mediated elevations of gonadotropin 
serum levels. Secondly possible modulating effects were studied of different modes 
and doses of LH-RH on gonadotropin induced steroid biosynthesis. 
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Materials and methods 
Eighteen healthy normal men between 23 and 43 years of age volunteered for this 
study after informed consent. Sperm analyses in all subjects were normal with sperm 
counts above 20 χ 106/ml, less than 40% abnormal forms and at least 60% of the 
sperms having good forward motility. All the studies started at 5:00 P.M. There was 
no selection in the participation of the candidates for one or more test. The interval 
between different experiments in the same subject was at least one month. 
Study protocol 
Continuous LH-RH infusion: Synthetic LH-RH (Relefact, Hoechst Holland N. V., Am­
sterdam, The Netherlands) was administered to nine men by constant intravenous 
infusion (Harvard pump, Harvard Apparatus, South Natick, MA) for 3 hours through 
an indwelling catheter in one arm. The dose was chosen as I ug/minute (further men­
tioned as C( 1,1)). 
Pulsatile LH-RH administration: LH-RH was administered through venipuncture in 
one arm to eight men as a 20 ug bolus dose at 20 minute intervals (P(20,20)) and 
to eight men as a 60 ug bolus dose at 60 minute intervals (P(60,60)). The total dose 
of LH-RH administered during the test period was equal inali three experiments (180 
ug)· 
Blood was obtained by a constant withdrawal pump through a heparin-coated cath­
eter (Kowarski catheter; Cormed, Middleport, New York) which was introduced in 
an antecubital vein of the arm where no LH-RH was administered. Blood was collected 
in 15 minute aliquots (10 ml each) starting 15 minutes before LH-RH administration. 
The first sample represents the baseline value. After centrifugation the serum was 
stored at — 20CC until assayed. Serum LH and FSH levels were determined in all 
the 15 minute samples. Measurements for serum Τ and E2 levels were performed at 
limited intervals. Due to the lack of a sufficient amount of serum available the 17-OHP 
levels were only determined at t = 0,75,105,135,165 minutes, whereas in the P(60,60) 
experiment additional sampling intervals could be measured. 
Hormone assays 
Serum LH and FSH concentrations were determined by specific radioimmunoassay4 
(intra assay replicate variation 8.6 and 8.1% respectively). Dextran-coated charcoal 
(DCC) radioimmunoassay was used to determine serum Τ and E2 levels and included 
the use of Scphadex LH-20 chromatografic purification in the E2 assay. The between-
assay variability was 9.3% at a Τ level of 9.0 nmol/1,5 while the coefficients of variation 
for the within and between-assay variability of means of duplicate E2 measurements 
as calculated from several pools of serum was 6.2% and 9.0% respectively.6 17-OHP 
concentrations were measured by specific DCC radioimmunoassay after organic sol­
vent extraction of the serum samples with diethylether and the subsequent isolation 
of the 17-OHP containing fraction following Sephadex LH-20 (Pharmacia Fine Chem­
icals AB, Uppsala, Sweden) column chromatography. The assay applied an antiserum 
raised in rabbits and directed against 17-OHP-7-carboxyethylioether-BSA (Radioas-
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say System Laboratories, Carson, CA, USA), the (Ι,Ζ,ό,ΤΉ) 17-OHP (Amersham 
international pic, Amersham, UK) as a radioactive label, while 17-OHP (Sigma Chem­
ical Company, St Louis, Mo, USA) was used in the range from 0 025-3 0 pmol/tube 
as the standard preparation. Cross-reactivities of a variety of C18- C19-, and C21-
steroids were always less than 0 01% while progesterone and 17-hydroxypregnenolone 
showed 0 4% and 1 1% cross-reaction, respectively. To further evidence the absence 
of any cross-reactivity of several progestagens including progesterone in the 17-OHP 
RIA-system small portions of stock solution, prepared with substantial amounts of 
these steroids, were added to serum samples before extraction This procedure failed 
to show any significant increase of the 17-OHP concentrations after its chromatografic 
isolation as compared with the endogenous 17-OHP serum concentration Method 
blanks were not different from the initial binding B0 and were thus below the minimum 
detectable dose (0 02 pmol 17-OHP/tube at B/B0 = 0 9) The intra and inter-assay 
variabilities for means of duplicate measurements were calculated from a pool of serum 
(mean concentration. 7 5 nmol/l) and were 7 5% and 8 5%, respectively 
Statistical analysis 
Description of the mean response curve For each of the measuring time points the 
mean of the logarithm of the serum concentrations with respect to the mean baseline 
value is judged for its statistical significance by means of the Student one sample test 
(P values denoted by P) Comparisons of the different types of LH-RH administration: 
Due to the incompleteness of the experimental design it was decided to make mutual 
comparisons among the three different administration types. This comparison is done 
with respect to the mean increase in serum concentrations as well during the first hour 
as during the three hour penod after the start of the LH-RH administration In the 
comparison of the mean increase among a pair of administration types an adjustment 
was made for the difference in baseline val ue, since the increase is likely to be dependant 
upon this baseline value This statistical procedure has been described in detail pre­
viously.4 (P*) 
Results 
Serum LH levels (Fig. 1) 
All three modes of LH-RH administration were followed by rapid and significant 
LH increments (at 15 minutes mean concentrations were at least 1 4 χ the baseline 
value, all Ρ values < 0 05) A peak in the mean level was reached in all groups after 
30-45 minutes (3 1-3 9 χ the baseline value) Afterwards the mean LH levels virtually 
plateaued until the end of the test period 
Serum FSH levels (Fig. 1) 
Following all the applied modes of LH-RH administration a small but progressive 
increase was noticed with statistically significant elevations from 15- 30 minutes on 
(mean concentrations at least 1.2 χ the baseline value, all Ρ values < 0 05), and maxi-
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Figure 1 
Percent changes (mean + SEM) of Ι H and FSH serum 
levels during LH-RH administration, given either contin­
uously (C(l,l)) or in a pulsatile fashion (P(20,20) and 
P(60,60)) in normal men 
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Figure 2 
17-OHP, Τ and E2 scrum levels (mean ± SEM) dunng 1 H-RH administration, given either continuously (0(1,1)) or 
in a pulsatile fashion (P(20,20) and P(60,60)) in normal men The asterisks indicate statistically significant changes as 
compared with the baseline value (*)P<OIO * P < 0 05 * * P < 0 01 * * * P < 0 001 
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mum mean levels at the end of the test period (1.7-2.0 χ the baseline value). The 
absolute LH and FSH response curves were described in detail earlier.7 
Serum Τ levels (Fig. 2) 
During continuous LH-RH infusion (C(l,l)) a rapid increase of mean serum Τ levels 
was noticed with an initial peak at 15-30 minutes ( 1.4 χ the baseline value, Ρ < 0.001 ) 
followed by a nadir at 60 minutes (P < 0.05 versus t = 15-30 minutes), a second rise 
and plateauing serum levels from 90 minutes on. During the pulsatile LH-RH adminis­
tration at 20-minute intervals (P(20,20)) a similar biphasic response pattern did occur 
with the initial mean peak concentration at 15 minutes (1.5 χ the baseline value, 
Ρ < 0.01) and a nadir at 60 minutes (P < 0.05 versus t = 15 minutes). After a second 
increase with maximum levels at 90 minutes (P < 0.05 versus t = 60 minutes) the mean 
serum levels plateaued. Pulsatile LH-RH administration at 60-minute intervals 
(P(60,60)) did not evoke statistically significant Τ changes during the 45 minutes fol­
lowing the fist bolus injection. Afterwards the mean Τ levels progressively increased 
with significant elevations onward from 60 minutes to the maximum mean level ob­
served at the end of the test period (1.4 χ the baseline value, Ρ < 0.01). 
The overall Τ release in the three hour test period is equal in all the three experiments 
(P* ^ 0.38). As could be expected Τ release in the first 60 minutes after initiation 
of LH-RH administration is statistically significant higher (P* < 0.007) in the C(l,l) 
and P(20,20) versus the P(60,60) experiment. 
Serum E2 levels (Fig. 2) 
In contrast to Τ the mean serum Ej levels did not show statistically significant eleva­
tions in any of the three experiments. During the C( 1,1) and P(20,20) administration 
oscillating changes and a downward trend was observed in the mean E2 levels with 
lowest values at 165 minutes (0.6 χ the baseline value, Ρ < 0.01) in the C(l,l) experi­
ment and at 135 minutes (0.7 χ the baseline value, Ρ = 0.07) in the P(20,20) experi­
ment. The mean Ej serum level remained unchanged in the P(60,60) experiment. 
Serum 17-0 Η Ρ levels (Fig. 2) 
Early 17-OHP response patterns are unknown in the C( 1,1) and P(20,20) experiments. 
As far as the second part of the curve is concerned mean peak levels were reached 
at 135 minutes (1.7 χ the baseline value, Ρ < 0.05) in the C(l,l) experiment and at 
105 minutes (1.6 χ the baseline value, Ρ < 0.05) in the P(20,20) experiment. In the 
P(60,60) experiment the 17-OHP profile could be completely followed. After declining 
mean levels following the first 60 ug bolus dose (at 15-30 minutes 0.8 χ the baseline 
value, Ρ < 0.01) mean levels increased from 45 minutes on (at 75 minutes 1.4 χ the 
baseline value, Ρ = 0.05) and reaching their maximum of 1.6 χ the baseline value at 
165minutes(P<0.01). 
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Discussion 
In the present study the effects of LH-RH induced elevations of circulating LH and 
FSH levels on Leydig cell steroidogenesis were examined in normal men, using an 
integrated blood sampling technique to avoid inadequate hormone estimations due 
to the pulsatile nature of hormone discharge 
Only scarce and inconsistent data are available m the literature regarding the effects 
of short-term LH-RH infusion on Leydig cell function in normal men As far as acute 
Leydig cell stimulation by bolus injections of LH-RH is concerned Nankin et a l 8 failed 
to demonstrate any statistically significant changes in serum Τ levels whereas Schwarz-
stein et a l 9 reported significant Τ increments already 8-32 minutes after a 50 ug 
LH-RH bolus dose. A similar discrepancy of Leydig cell response was observed after 
the infusion of LH itself Nankin et al 10 reported that after 90-120 minutes a statisti­
cally significant increase of 15% and 25% was observed for Τ and 17-OHP levels, 
respectively. Wang et al " infusing LH noticed a biphasic Τ response pattern with 
initial Τ increments within 3 hours (peak levels at 45-75 minutes) So far no direct 
gonadal effects of LH-RH on Leydig cell function has been demonstrated in men 
In the present study, irrespective of the mode or dose of LH-RH administration, 
the observed mean Τ increments were rather small (1 4-1 5 χ the baseline value) as 
compared to the mean LH elevations Furthermore the overall Τ release during the 
test was similar m all the three experiments The C(l,l) and P(20,20) experiments, 
however, showed a biphasic Τ response pattern From 90 minutes on no further incre­
ments in mean Τ levels did occur in spite of continuous Leydig cell stimulation by 
persistent LH elevations In either experiment the initial Τ peak was already observed 
at 15 minutes, whereas by that time the LH levels had increased to only half of their 
maximum values This agrees with observation of Rommerts et a l l 2 demonstrating 
that androgen synthesis can occur very fast since the first stimulation of steroidogenesis 
was observed within 5 minutes following LH exposure to rat Leydig cells in vitro. 
In contrast to these observations, in the P(60,60) experiment no statistically significant 
initial increase did occur in Τ levels following the first 60 ug bolus dose, despite an 
overt increase of the mean LH levels From 45 minutes on, however, the mean Τ levels 
increased significantly until the end of the test period The present data does show 
the acute Τ increase observed in the C(l,l) and P(20,20) experiments to be absent 
during the P(60,60) administration In view of the similar LH and FSH increments 
in response to LH-RH in the three experiments the differences in Τ responses may 
be explained by assuming a direct effect of LH-RH on Leydig cell function in the 
men. The absence of a transient accumulation of 17-OHP over Τ levels, as observed 
in Oligospermie men following LH-RH infusion,11 indicate that a 'late' steroidogenic 
lesion in androgen biosynthesis (impaired activity of 17 20 lyase enzym) is not a likely 
explanation for the lack of an early Τ rise in the P(60,60) experiment The absence 
of significant Ej elevations too is in agreement with the above mentioned statement1 4 
The lack of the initial Τ increase in the P(60,60) experiment may be due to a defect 
'early' in the steroidogenic pathway, prior to the conversion of 17-OHP to T, or possi­
bly at the LH receptor level of Leydig cells. Studies on this subject have not been 
conclusive so far.15 Sharpe et a l 1 6 mentioned time related changes of direct (inhibitory 
or stimulatory) testicular effects of LH-RH The observations of the present study 
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are in favour of dose related changes since an acute release in serum Τ levels could 
occur in the C(l,l) and P(20,20) experiment in the presence of low LH-RH serum 
concentrations shortly after the initiation of the administration of the decapcplide. 
In conclusion, three different modes of LH-RH administration, which elicited gona­
dotropin responses of a comparable magnitude, were followed by an equal overall 
Τ release but clearly different Τ response patterns. These data favours the concept 
of a direct effect of LH-RH itself on Leydig cell steroidogenesis in normal men. 
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CHAPTER V 
LONG-TERM, PULSATILE, LOW DOSE, 
SUBCUTANEOUS LUTEINIZING HORMONE-
RELEASING HORMONE ADMINISTRATION IN 
MEN WITH IDIOPATHIC OLIGOSPERMIA. 
FAILURE OF THERAPEUTIC AND HORMONAL 
RESPONSE 
BCJM Fauser, R Rolland, JMJ Dony, RS Corbey 
(Published in Andrologia 17:143, 1985) 
Abstract 
In four normal men with a history of long standing infertility, severely disturbed sperm 
qualities (determined in at least three spermiograms), normal serum LH and FSH 
levels (measured over a time period of 90 minutes), and lack of evidence of further 
andrological or other obvious endocrine disorders the effectiveness of LH-RH treat­
ment was investigated. LH-RH was administered subcutaneously with a portable, 
computerized infusion pump (Zyclomat) for 3 months, with administration intervals 
of 90 minutes and bolus dosages of 5 ug (three patients) and 20 ug (one patient). 
Semen qualities during and after LH-RH treatment, as compared to pretreatment 
values, showed no improvement in volume of ejaculate, number of sperms per milliliter 
and motility. During or at the end of the treatment period no evident differences were 
observed in serum LH, FSH and Τ levels (measured over a 90 minutes period) com­
pared with hormonal values before LH-RH therapy, nor at the low-dose (5 ug) neither 
at the high-dose (20 ug) administration schedule. It is concluded that pulsatile subcu­
taneous LH-RH treatment in normogonadotropic, Oligospermie men does not seem 
to improve the therapeutical arsenal. 
Introduction 
The initial use of synthetic LH-RH in the treatment of Oligospermie men1 3 was dis­
appointing. Recently the importance of the precise pattern of pulsatile endogenous 
LH-RH discharge for pituitary stimulation has been recognized in monkeys.4 This 
has led to a renewal of interest using this type of LH-RH therapy. Pulsatile LH-RH 
administration in a dosage schedule mimicing the assumed pattern of physiological 
LH-RH secretion, has proven to be successful in induction of ovulation in women 
with hypogonadotropic amenorrhea.56 This type of LH-RH treatment also induced 
sustained testicular function and spermatogenesis in men with hypogonadotropic hy­
pogonadism.7·8 LH-RH was administered iv. as well as sc. with a portable, computer­
ized pump. 
In the group of men with idiopathic oligospermia the causes and circumstances 
which underlie decreasing spermatogenesis are still unknown. Minor endocrinological 
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disturbances in the hypothalamic - pituitary - gonadal axis, or within the gonads 
theirselves, may not be diagnosed by routine hormonal measurements in peripheral 
plasma. Recently differential Leydig cell responses following LH-RH infusion were 
noted in normal and Oligospermie men.9 Considering the possibility that the group 
of men suffering from idiopathic oligospermia may at least in part include individuals 
with abnormalities involving the hormone action on the testis10 it seems useful to inves­
tigate the influence of long-term, low dose, pulsatile LH-RH administration on hor­
monal parmeters and sperm qualities in this group. 
Materials and Methods 
Patient population 
All couples consulted the outpatient department because of infertility and at the time 
the LH-RH treatment was started the infertility had lasted for at least three years. 
No serious abnormalities explaining the infertility were found in the wives. Before 
the administration of LH-RH no other medication was taken by the men for at least 
6 months. All four patients showed severely disturbed sperm qualities (Fig. 1), deter­
mined in at least three spermiograms, without obvious endocrinological or andrologi-
cal problems. No obvious abnormalities were found by routine examination of the 
external genitalia. A normal libido and potency was present. The clinical details of 
the four patients are summarized in Table 1. 
Table I Clinical Summaries of the Four Oligospermie Men 
Subject 
1 
2 
3 
4 
Age 
(years) 
31 
30 
29 
29 
Wcighl 
(kg) 
96 
89 
79 
70 
Height 
(m) 
1.86 
1.80 
1.70 
1.76 
Years of 
infertiliiv 
3 
7 
3 
3 
Previous 
therapy 
no 
HMG/HCG 
Clomiphcne 
Clomiphene 
LH-RH 
bolus dose 
5 
5 
5 
20 
Study protocol 
LH-RH was administered intermittent by means of a portable, computerized infusion 
pump (Zyclomat, Ferring, GmbH, Kiel, West-Germany) for 3 months, without inter­
ruption. The pump was connected to an indwelling catheter inserted subcutaneously 
into the fatt tissue of the lower abdominal wall. The pump delivered 5 or 20 ug LH-RH 
(Ferring) in a 50 μΙ saline solution (during a period of 1 min) every 90 min. No heparin 
was added to the solution. The men visited the outpatient department every 10 days 
for new supply of the LH-RH solution. Before commencement of the LH-RH adminis­
tration baseline serum LH, FSH and Τ levels were determined over a 90 min period, 
with 15 min intervals. This sampling procedure was repeated at the end of the 3 months 
treatment period just prior to the removal of the pump with the first sample taken 
immediately after the pump had delivered a bolus dosage of LH-RH. During the treat­
ment period blood controls were performed every 10 days. Spermiograms were per-
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formed before, at the start and after 6 weeks - and 3 months - of treatment. Finally 
a sample was analyzed 3 months after the LH-RH administration had stopped. Semen 
was obtained by masturbation after 3 days of abstinence and analyzed within 2 hours. 
Each specimen was analyzed for volume of ejaculate, sperm count per ml ( χ IO6) and 
percentages of motile sperms (Fig. 1 ). Prior to treatment the diagnosis of oligospermia 
was based on at least 3 spermiograms, taken with at least 1 month interval, with sperm 
counts less than 30 χ 106/inl and in all samples less than 30% sperms having good 
forward motility. 
Hormonal assay characteristics 
Serum LH and FSH concentrations were measured by specific, homologous double-
antibody, solid-phase radioimuunoassay as described by van Geelen et al." LH is 
expressed in IU/L (MRC 68/40), as is FSH (MRC 69/104). The coefficient of variation 
for the within and between assay variability of means of duplicate measurements, as 
calculated from several pools of serum, is 8.6% and 16,3% respectively for LH and 
8,1% and 13.5% respectively for FSH. Dextran-coated charcoal (DCC) radioimmuno­
assay was used to determine serum T.12 The between assay variablity was 9.3% at 
a Τ level of 258 ng/dl. All samples from one candidate were determined in the same 
assay run. 
Results 
Serum concentrations of LH, FSH and Τ before and during 90 days of sc. pulsatile 
treatment with 5 or 20 ug LH-RH, every 90 minutes, are presented in Fig. 2 and 3. 
Baseline LH, FSH and Τ levels, measured over a 90-minute period, were within the 
normal range for our laboratory, although LH levels in subject 4 were rather high 
volume of 
ejaculate 
(ml) 
cone sperms/ml 4 0 
(»IO6) 
20 4 
Subject 2 Subject 3 Subject U 
ι—ι—i— 
i 1 i I 
τΛΊΊΊΊν,'λ'Λ 
'I* sperms with 40 
good motility 
20 
О 
läm π?*" 
I D Ш І П Ш І П Ш 1 D Ш 
Figure 1 
Sperm qualities in 4 Oligospermie men before (I), during (II) and after (III) LH-RH 
treatment (Mean values are presented) 
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Figure 2 
Serum levels of LH (O 0 ) . F S H ( # · ) and Τ before. 
dunng and at the end of a 90 days, pulsatile (4 ug) LH-RH 
treatment in 3 Oligospermie men 
and close to the upper level of normal (Fig. 3). During the entire treatment period 
no obvious and systemic changes appeared in the hormone levels. Even immediately 
following a 5 or 20 ug bolus dosage at the end of the 3 months treatment period no 
significant hormone changes did occur in peripheral plasma, as measured over a 
90-minute period. Sperm qualities, expressed in volume of ejaculate, number of 
sperms/ml and percentage of sperms having good forward motility before, during and 
after LH-RH treatment are given in Fig. 1. During the entire period of investigation 
no qualitative or quantitative improvement in sperm qualities was seen. The medica­
tion was well accepted. All candidates could continue their daily duties and no compli­
cations were reported. Also no changes in sex performance were encountered. 
20/jg LH-RH/90 mm 
Subject i LH/FSH 
(lU/l) 
Τ 
(ng/ЮОтІ) 
зо -, 
2 0 -
ю -
0 -
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4 0 0 -
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/V 
^ 
М М М 
0 1 
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LH-RH bolus 
··.-·-.-·., 
ι 1 1 1 ' — τ 1 — 1 Γ Τ Γ Γ Ι 
10 20 30 40 50 60 70 80 0 1 
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Figure 3 T i m e 
Serum levels of LH (О О ). FSH ( φ — · ) and Τ before, during and at the end ofa 90 days, 
pulsatile (20 ug) LH-RH treatment in 1 Oligospermie man (Not all hormonal values are 
presented) 
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discussion 
The aim of LH-RH treatment in idiopathic oligospermia is to improve spermatogene­
sis in cases in which the pituitary gonadotropin secretion is apparently normal but 
with assumed inadequate intratcsticular Τ concentrations Indeed, in men presenting 
with infertility a clear gonadotropin deficiency accounts for only a very small part 
of the causative factors13 However, in vitro studies measuring steroid biosynthese 
activity of testicular tissues obtained by biopsy14 support the theory of decreasing intra-
testicular steroidogenesis in patients with oligospermia and normal serum gonadotro­
pin levels. The recent finding9 of impaired Leydig cell activity in Oligospermie men 
is in agreement with this in vitro observation Unfortunately, until now, no clear para­
meters have been provided for the selection of patients who may benefit from hormon­
al treatment The advantage of LH-RH over other hormonal agents is the fact that 
endogenous gonadotropins are involved as are the feedback mechanisms of sex ster­
oids on the pituitary gland A further reason is the recent finding that LH-RH acts 
directly within the gonads and may therefore play a local modulating role in Leydig 
cell function.15 This direct gonadal effect of LH-RH, however, was only demonstrated 
in animal studies The physiological significance of this LH-RH activity remains to 
be solved in men, although an LH-RH-like factor was also demonstrated in human 
seminal plasma 16 In Oligospermie men synthetic LH-RH was previously administered 
im. once or twice daily, in dosages varying from 100 to 1000 ug, for 1 to 6 months ' 1 
The unphysiological mode of LH-RH administration appeared to be the cause of the 
rather disappointing therapeutic results. For the same reason, but also due to their 
desensitization effect, the use of LH-RH analoques appeared Lo be ineffective 1 7 1 8 
We have evaluated the hormonal and therapeutic response of Oligospermie men 
to long-term, low dose, pulsatile, sc. LH-RH therapy The four men were treated for 
3 months. Hormonal blood levels were determined and sperm analyses were performed 
before, during and after the treatment period Although the number of investigated 
subjects is small, our preliminary results are disappointing LH-RH treatment using 
a dosage schedule mimicing the assumed pattern of physiological LH-RH secretion 
in men did not result in measurable qualitative or quantitative improvement of sperm 
qualities (Fig 1) No pregnancies were observed following this treatment schedule. 
No hormonal (LH. FSH and Τ) changes could be discovered in peripheral plasma, 
nor at the low dose (5 ug dosage) neither at the high dose (20 ug dosage) administration 
schedule (Fig 2 and 3) 
The poor therapeutic results in this pilot study does not necessarily means that 
LH-RH may not be of value in Oligospermie men There are some possible explana­
tions for the mentioned therapeutical failure in this study The inferior results of the 
present study seem to support the theory that the possible causes of impaired spermato­
genesis in idiopathic oligospermia are very heterogeneous and that specific hormonal 
treatment may only be possible in a small proportion of infertile men after an accurate 
diagnosis has been made A second possible explanation for the lack of therapeutic 
response is the chosen bolus dosages of 5 or 20 ug which may have been to low, or 
the chosen route of administration which may have been ineffective We have chosen 
for the sc route of LH-RH administration because we believed it to be the most com­
fortable and safe way for the patients. The absence of clear hormonal changes shortly 
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after a LH-RH bolus dosage in this study suggests that the used dosage schedule is 
not sufficient. Hence, good results are reported in hypogonadotropic women using 
this type of sc. administration with bolus dosages varying from 1 to 20 ug.19·20 The 
used dosage schedules are mostly based on earlier estimates of the endogenous LH-RH 
levels in pituitary portal plasma of the human.21 A third explanation for the failure 
of response may be a possible interference between administered and endogenous 
LH-RH, a problem which should not exist if LH-RH was administered in hypogonadal 
males only. This possible interference has not been subject of any particular study 
so far, but may be solved in the near future since a more sensitive radioimmunoassay 
for measuring LH-RH in human peripheral plasma has become available.22 
The absence of any measurable hormonal change in peripheral plasma in this study 
suggests that no intra-testicular hormone change has occured and hence also no signi fi-
cant changes in sperm qualities were seen. If intra testicular hormone changes did occur 
they were insignificant in the sence that they were unmeasurablc in peripheral plasma 
and in sperm qualities. It seems therefore that the most likely explanation for the 
absence of a therapeutical and hormonal response after sc, low dose, pulsatile LH-RH 
administration in Oligospermie men must have been the great heterogenity of the 4 
investigated men. The used dosage schedule has proven to be effective in hypogonado­
tropic men,78 hence better selection criteria are necessary in idiopathic Oligospermie 
men to hopefully select a subgroup which may benefit from this form of therapy. 
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CHAPTER VI 
SERUM LUTEINIZING HORMONE-RELEASING 
HORMONE (LH-RH) AND GONADOTROPIC 
HORMONES IN MEN AFTER A BOLUS DOSE OF 
LH-RH: COMPARISON OF DIFFERENT DOSES AND 
ROUTES OF ADMINISTRATION 
BCJM Fauser, R Rolland, CMC Thomas, WH Doesburg, JMJ Dony 
(Fertility and Sterility. 1985. In Press) 
Abstract 
Serum levels of LH-RH, LH and FSH, were measured for 60 minutes following 5 
and 20 ug bolus doses of LH-RH given either intravenously or subcutaneously to 
20 healthy men, to study LH-RH pharmacokinetics and the corresponding pituitary 
gonadotropin release. 
Intravenous (5 and 20 ug) LH-RH administration revealed much sharper LH-RH 
pulses with significantly higher levels between 1 and 5 minutes (P < 0.001), but lower 
levels between 30 and 60 minutes (P < 0.05) as compared with the subcutaneous route. 
No statistically significant differences were observed in the magnitude and time occur-
rence of maximum LH release as well as the area under the LH response curves between 
intravenous and subcutaneous LH-RH administration, either in the 5 ug or in the 
20 ug group. FSH responses were small and insignificant in all the perfomed tests. 
The intravenous route of administration seems preferential in therapeutic regimens 
using pulsatile exogenous LH-RH, since the conditions of intermittent pituitary stimu-
lation are more adequately fulfilled and the risk of dose accumulation is reduced. 
Furthermore, LH-RH doses of 5 ug are capable of producing adequate pituitary LH 
release whereas increasing the pulse dose up to 20 ug seem to have no additional effects. 
Introduction 
To obtain prolonged pituitary gonadotropin secretion exogenous LH-RH must stimu-
late the gonadotrope in a pulsatile fashion. Low-dose, intermittent LH-RH adminis-
tration has appeared to be of therapeutic value in men and women presenting with 
hypogonadotropic hypogonadism.' Successful therapy depends on the pulse-dose of 
LH-RH, the pulse-frequency and the route of administration, since previous studies 
established that different modes and doses of LH-RH stimulation are important for 
the magnitude of pituitary gonadotropin release.2 4 The majority of investigators5 '0 
uses 90-minute intervals between pulses assuming this to represent episodic endoge-
nous LH-RH discharge. Based on both indirect estimations of LH-RH levels in portal 
blood in men" and on clinical experience the applied LH-RH pulse doses ranged be-
tween 1 and 20 ug. Apart from the optimum bolus dosage a great deal of controversy 
exists with regard to the most appropriate route of administration. Some authors7"9·12 
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claimed the subcutaneous route to be most favourable because it lacks the inherent 
risks or discomfort of intravenous catheters. Conversely others6·10 suggested the subcu­
taneous route to be ineffective. The clinical advantage of intravenous administration 
is probably related to the pattern of LH-RH levels achieved in the blood. Furthermore, 
the lowest effective LH-RH dosage is preferential from an economic point of view. 
As data concerning the physiology of pituitary function in men are accumulating, 
it becomes important to understand whether the used LH-RH administration regimens 
in hypogonadotropic hypogonadism mimic the natural conditions in the human or 
not. Until now little attention has been paid to detailed pharmacokinetics of different 
modes and doses of exogenous LH-RH. Very recently preliminary data became avail­
able concerning LH-RH and LH measurements in peripheral plasma following low-
dose LH-RH administration in the human.13 I6 The present study is the first to syste­
matically compare the effect of subcutaneous versus intravenous LH-RH administra­
tion to clarify in men more precisely the optimum dose and route of exogenous LH-RH 
administration. 
Materials and methods 
Informed consent was given by the 20 healthy men who participated in this study. 
Their mean age was 27.1 ± 8.9 (standard deviation; SD) years and their weight 76.1 
± 8.5 (SD) kg. They did not suffer from any overt endocrine disorder. Synthetic 
LH-RH (Relefact, Hoechst Holland NV, Amsterdam, The Netherlands) was admin­
istered as a 5 ug bolus dose given intravenously either into the arm (n = 5) or subcutan-
eously into the fat tissue of the lower abdominal wall (n = 5). A 20 ug bolus dose 
was also administered intravenously (n = 5) and subcutaneously (n = 5). No selection 
was performed between the candidates for different tests. All test procedures started 
at 2:00 P.M. Any type of LH-RH administration was given as a 0.2 ml saline solution. 
Blood samples for LH-RH, LH and FSH measurements were collected at t = - 10, 
— 5, 0, 1, 3, 5, 10, 15, 20, 30, 45, 60 minutes, respectively, where t = 0 indicate the 
time point of LH-RH administration. After ccntrifugation the serum for gonadotropin 
and plasma samples for LH-RH measurements were stored at —20ο€ until assayed. 
All samples from one individual were measured in the same assay run. 
Hormone assays 
Serum LH and FSH levels were determined by a double-antibody, solid phase radio-
immunoassay (RIA) technique.17 Concentrations are expressed in IU/L of the first 
International Reference Preparation (IRP) of human pituitary LH (M RC 68/40) while 
the second IRP of human pituitary gonadotropins LH and FSH for bioassay (MRC 
78/549) was used in the case of FSH. The coefficients of variation for the wi thin-assay 
and between-assay variabilities for means of duplicate measurements are 8.6% and 
16.3% for LH, and 8.1% and 13.5% for FSH, respectively. 
Plasma LH-RH was assayed by a double-antibody, solid phase RIA using the LH-
RH 125I kit (Euro-Diagnostics B.V., Apeldoorn, The Netherlands). The reagens in-
cluded are anti LH-RH antiserum raised in rabbits, standard LH-RH, radioiodinated 
LH-RH and goat anti-rabbit gamma globulin as the second antibody for bound-free 
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separations. RIA was performed by pre-incubating duplicate samples of standards 
(range: 5 to 320 ng/L, 7 dose-levels) and unknowns with antiserum for 6 hours at 
4 0 C and this was followed by incubation with l25I-LH-RH during 18 hours at 4 0 C. 
The antibody-bound and free analyte were separated with the second antibody solid 
phase reagent after an incubation period of 30 minutes at room temperature and sub­
sequent centrifugation for 10 to 15 minutes at 2000 χ g. The bound radioactivity in 
the precipitate was counted and the LH-RH concentrations of unknowns were calcu­
lated using logit-log transformation procedures. Previous to RIA, unknown samples 
were extracted with ethanol to remove plasma proteins which interfere in the assay 
system. The specificity of the method as documented by the supplier in terms of cross-
reactivities (determined at 50% displacement on a weight basis compared with native 
LH-RH) was 100% with LH-RH, LH-RH-OH, Ac-His-LH-RH, LH-RH1 », and 
< 0.01% with LH-RH 3 1 0 , and LH-RH* 'o. Further tests were performed and showed 
cross-reactivities of < 0.01% with LH-RH 4 6 , and < 0.5% with LH-RH 1 1 and 
LH-RH7 10. LH-RH4 l 0 revealed 3.5%. The sensitivity of the assay was 3 ng/L at 90% 
B/B0 whereas the precision in terms of intra-assay and inter-assay variabilities for 
duplicate measurements derived from several pools of plasma were 9.8% and 14%, 
respectively. Individual baseline values of endogenous LH-RH in peripheral plasma 
were often below the assay sensitivity. 
Statistical analysis 
Within the same bolus group, at each measuring time point the serum levels of LH-RH, 
LH and FSH were compared between intravenous and subcutaneous administration 
by means of the Student t-test (unpaired case) performed on the logarithm of the 
serum concentrations. LH-RH response curves after both types of administration were 
also compared with regard to the surface under the curve (but above the level at t = 0), 
the highest of the measured levels and the time point this peak level was found, the 
speed of increase after LH-RH administration and of the decrease after the peak level 
has reached. For these four parameters also the mean of the individual values is calcu­
lated. Mean values + 1 standard error of the mean (SEM) are presented unless other­
wise stated. 
Results 
Serum LH-RH levels 
The area under the LH-RH curves during the 60-minute test period did not reach 
a statistically significant difference comparing intravenous and subcutaneous LH-RH 
administration (4572 + 1379 versus 2042 ± 410, Ρ = 0.09 for the 5 ug experiment 
and 11375 + 3025 versus 9207 ± 1496, Ρ = 0.53 for the 20 ug experiment). However, 
overt differences were observed in LH-RH profiles with significantly higher levels be­
tween 1 and 5 minutes (P < 0.001) but lower levels between 30 and 60 minutes 
(P < 0.05) in the case of intravenous LH-RH administration (Fig. 1). 
Low dose LH-RH: The intravenous route as compared to subcutaneous administration 
produced both earlier (2.0 ± 1.0 versus 15.0 + 2.9 minutes) and higher (825 ± 45 
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Figure 1 
Serum LH-RH levels (mean + SEM) following the administration of a S or 20 ug LH RH 
bolus dose, given cither intravenously ( φ — φ) or subcutancously (O - О ) to 20 men (each 
group η = 5) The astenks indicale statistically significant differences between intravenous 
and subcutaneous LH-RH administration at a time *P < OO1) **P < 0 0l · * * Ρ < 0 001 
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Figure 2 
Scrum LH and bSH levels (mean ± SEM) following the administration of a 5 or 20 ug 
LH-RHbolusdose,giveneitherintravenously(# 9)orsubcutancously(0 О )to20men 
(each group η = 5) The astenks indicate statistically significant dirfercnces between intra­
venous and subcutaneous LH-RH administration at a time * P < 0 05 * * P < 0 01 
" * P < O O 0 l 
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versus 73.3 + 18 ng/L, Ρ = 0.003) mean peak levels. After achieving the peak level 
serum LH-RH levels demonstrated a 50% decline within 2.2 + 0.6 minutes after intra­
venous and within 25.4 ± 5.2 minutes after subcutaneous administration. After 60 
minutes the serum levels had not yet returned to baseline values in either experiment 
(8.4 + 1.0 versus 4.6 + 0.5 ng/L and 20.3 ± 3.3 versus 4.1 + 0.4 ng/L for intravenous 
and subcutaneous administration, respectively). 
High dose LH-RH: A 20 ug bolus dose produced earlier (1.7 + 0.7 versus 15.0 + 
1.6 minutes) and higher (1236 + 315 versus 260 + 46 ng/L, Ρ = 0.002) mean peak 
levels following its intravenous versus subcutaneous administration. A 50% decline 
in serum levels was reached within 5.6 + 1.0 and 27.4 + 3.7 minutes, respectively. 
After 60 minutes the serum levels were still elevated, as compared to baseline values, 
in either experiment (29 + 13 versus 4.1 + 0.4 ng/L and 8 4 + 1 9 versus 4.1 + 0.7 
ng/L for the intravenous and subcutaneous route of administration, respectively). 
Serum LH levels 
Low dose LH-RH: The area under the LH response curves was not significantly differ­
ent after intravenous or subcutaneous LH-RH administration (583 + 144 versus 304 
+ 89, ρ = 0.12). Also no significant differences in mean LH levels on each of the 
separate time points were noted between either administration. The maximum level 
was reached after 20 minutes (ALH 12.2 + 2.5 IU/L) after intravenous and 30 minutes 
(ALH 9.5 + 1.5 IU/L) after subcutaneous administration (Fig. 2). A significant de­
crease of mean serum levels could not be observed in any experiment for the 60-minute 
observation time. 
High dose LH-RH: The area under the LH response curves was almost equal following 
intravenous and subcutaneous LH-RH administration (680 + 66 versus 615 + 88, 
Ρ = 0.46) but significantly higher levels occurred for LH (Ρ < 0.05) between 3 and 
15 minutes in the case of intravenous administration (Fig. 2). The peak level was 
reached 45 minutes (ALH 13.5 + 0.8 IU/L) after intravenous and 30 minutes (ALH 
12.5 + 1.8 IU/L) after subcutaneous administration. A decline in mean LH levels 
was not observed in either experiment. 
When serum LH levels on each of the separate time points are compared between 
20 ug subcutaneously and 5 ug LH-RH intravenously, beside at t = 5 minutes (lower 
concentration following 20 ug subcutaneously, Ρ = 0.04) no differences were observed 
(lowest? = 0.19), with similar areas under the curves (P = 0.85). 
Serum FSH levels 
Low dose LH-RH: The area under the FSH response curves was not significantly dif­
ferent after intravenous and subcutaneous LH-RH administration (40 + 2 versus 58 
+ 8, Ρ = 0.36) and also no significant differences of mean serum levels at separate 
time points were observed between either administration (Fig. 2). Maximum levels 
were reached 30 minutes after both intravenous (AFSH 1.3 f 0.3 IU/L) and subcutan­
eous (AFSH 1.6 + 0.7 IU/L) administration. 
High dose LH-RH: The area under the FSH response curves was almost equal follow­
ing intravenous and subcutaneous LH-RH administration ( 6 1 + 9 versus 69 + 22, 
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Ρ = О 99) as were the mean serum levels at separate time points for both groups (Fig 
2) The peak level was reached at 20 minutes (AFSH 14 + 0 2IU/L) after the intraven­
ous and at 60 minutes (AFSH 2 1 + 0 2 IU/L) after the subcutaneous administration 
Discussion 
The large difference observed for scrum LH-RH profile characteristics following either 
intravenous or subcutaneous LH-RH administration comprise much sharper LH-RH 
pulses reaching peak values at much shorter time intervals in the case of intravenous 
injection as compared to subcutaneous administration Also, the reached LH-RH 
maximum was higher with a much shorter interval of 50% decline The patterns of 
LH-RH serum levels, however, were similar after both 5 and 20 ug bolus iniections 
and serum LH-RH levels were still elevated after 60 minutes in all performed experi­
ments This was especially true in the 20 ug subcutaneous group 
The magnitude and time of maximum LH release and the area under LH response 
curves were not statistically significant different after intravenous versus subcutaneous 
(5 and 20 ug) LH-RH administration Furthermore, no statistically significant differ­
ences were found in the area under the LH response curve when the 20 ug subcutaneous 
and the 5 ug intravenous LH-RH administration were compared Although, in the 
5 ug group, the mean LH increase after intravenous injection exceeded subcutaneous 
administration by more than 50%, this difference was not statistically significant be­
cause the large inter-individual variability within the two groups and the relative small 
number of investigated subjects Significantly higher LH levels were only measured 
between 1 and 15 minutes after 20 ug LH-RH given intravenously as compared to 
subcutanous administration A significant decrease in mean LH levels was not ob­
served within the 60-minute test period in any of the experiments In recent reports13 l 6 
on LH-RH pharmacokinetics lower areas under both LH-RH and LH response curves 
are reported when the subcutaneous route is compared with intravenous LH-RH ad­
ministration In most cases decreasing LH levels were observed earlier than what we 
reported in this study However, the number of investigated subjects was small and 
therefore the data was limited The observed magnitude and time occurrence of peak 
LH levels in this report is in agreement with previous observations18 " in adult male 
volunteers It was observed that a clear decline of LH occurred only after 60 to 90 
minutes Furthermore, the observed magnitude of LH responses after exogenous LH-
RH in the present study agrees well with spontaneous ratios between highest and low­
est LH serum levels20 and the half-life of spontaneous episodic LH release was calculat­
ed as approximately 90 minutes. The profiles of FSH as measured in the present study 
also agree with previous observations of Snijder et al l 9 who showed FSH responses 
to LH-RH to be much less pronounced than LH and of limited value for pituitary 
stimulation tests 
Our data demonstrate an immediate peak of LH-RH in the blood followed by a 
rapid decline afterwards in the case of intravenous administration and a prolonged 
and delayed absorbtion of LH-RH when given subcutaneously However, irrespective 
of the type of administration there seems to be no obvious difference in the overall 
bioavailability if 20 ug is given because there is no statistically significant differences 
between areas under the LH-RH and LH response curves as observed after the intra-
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venous and subcutaneous LH-RH administration. In the 5 ug group a tendency to 
a difference in the area under the LH-RH curve is present (P = 0.09) and it is likely 
that this difference will become significant by increasing the investigated group. Dose 
accumulation of LH-RH (but also LH) will certainly occur when 20 ug bolus doses 
are given at 90-minute intervals, as performed in most therapeutic regimes5·7·9 and 
hence the physiological requirement of intermittent pituitary stimulation is violated. 
This is especially true for the subcutaneous route (mean serum LH-RH levels in the 
20 ug group are 20 times above baseline values at 60 minutes) but also using 5 ug 
pulse doses subcutaneously at 90-minute intervals8 '0 dose accumulation might occur. 
The magnitude of individual LH-RH elevations after intravenous (5 and 20 ug) LH-
RH administration (range 300-1600 ng/L) were well within the range of endogenous 
LH-RH levels, as measured in pituitary human blood.21 Hence, this route of adminis-
tration mimics the physiological circumstances. LH-RH measurements by RIA, how-
ever, cannot be accurately compared between different studies since biologically inac-
tive fragments may be differently recognized by different anti-LH-RH sera.22 It is of 
special interest that the differences in mean LH response patterns are small, although 
the LH-RH levels shows such a wide variation between the investigated groups. These 
data agree well with studies of Wildt et al.2 in the monkey and Mcintosh and Mcin-
tosh,3 who used a perfusion system of sheep pituitary cells, in which the LH release 
remained rather constant although the LH-RH dosage was increased 10-fold. Hence, 
it seems that above a fixed threshold no further stimulation of pituitary gonadotropin 
secretion will occur. This may also be the reason why Mortimer et al.21 observed a 
100 ug bolus dose of LH-RH to be equally effective in promoting LH and FSH release 
in men, irrespective whether it was given intravenously, subcutaneously or intramuscu-
lar. Mcintosh and Mcintosh1 also stressed the significance of the shape of the LH-RH 
pulse (steepness of the rising edge of the pulse) with respect to the magnitude and 
fastness of LH output. These results could not be confirmed by our observations in 
the human since the marked difference in the shape of the LH-RH pulse between 
intravenous and subcutaneous administration did not result in a concomitant statisti-
cally significant difference in LH response. This may be due to the relative short period 
of blood sampling and the large inter-individual variability, as mentioned previously. 
It seems justified to conclude from the presented data that from a pharmacokinetic 
and physiologic standpoint the intravenous route of administration is preferable to 
the subcutaneous route in therapeutic regimens using intermittent exogenous LH-RH 
administration because the purpose of rapid and intermittent pituitary stimulation 
is more defined and the risk of dose accumulation is reduced. The magnitude of LH-
RH stimulation is not of primary importance since a 5 ug dose is equally effective 
in promoting pituitary LH release as compared to a 20 ug injection. Hence, pulse 
doses of 5 ug, or maybe even less, aje capable of producing adequate pituitary LH 
release. 
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CHAPTbR VII 
GENERAL DISCUSSION 
The general aim of this thesis is to add to existing knowledge of hypothalamic and 
pituitary regulatory mechanisms in the male under normal conditions. Pituitary secre-
tion of LH and FSH is primarily regulated by hypothalamic LH-RH The functional 
activity of the LH-RH neuron can be affected by numerous neurotransmitters such 
as norepinephrine and acetylcholine which stimulate or inhibit LH-RH release ' Un-
fortunately, the pattern of LH-RH secretion in the portal circulation cannot be mea-
sured directly in the human A wide range of LH-RH levels (0-2000 pg/ml) was mea-
sured in human blood samples collected from the pituitary gland during neurosurgery 2 
This observation lends support to the concept of the pulsatile nature of hypothalamic 
LH-RH release. Several authors have reported on the measurement of LH-RH levels 
in peripheral human blood However, the rapid degradation of LH-RH3 and the mas-
sive dilution of pituitary portal blood by systemic blood (approximately 500-fold) 
results in very small quantities of this decapeptide in the peripheral circulation 4 Until 
now RIA measurements were insufficiently sensitive to quantify LH-RH levels reliably 
in peripheral plasma. Only one groupe has so far succeeded in measuring episodic 
LH-RH changes in human blood by RIA, they adduced direct evidence that LH-RH 
was released at approximately 60-min intervals In addition, estimates of endogenous 
LH-RH levels in the portal circulation (30-300 pg/ml) were made in the human by 
comparing LH-RH induced LH response patterns and spontaneous LH release 6 
All studies discussed in this thesis involved the administration of exogenous LH-RH 
to adult males Various modes and doses were employed Special attention was paid 
to pituitary gonadotropin response patterns under normal conditions following inter-
mittent LH-RH, using different types of amplitude- and frequency-modulated LH-RH 
administration In the past decade much research has been undertaken to explore phy-
siological mechanisms involved m the regulation of pituitary stimulation and release 
activity. Animal and human studies can be catagonzed in the following main sub-
groups according to their approach. 
Animal studies of the hypothalamic - pituitary axis 
/. Direct LH-RH measurement in the portal circulation The existence of intermittent 
hypothalamic LH-RH secretion was demonstrated by RIA measurements of this deca-
peptide in the portal circulation of rats,7 monkeys89 and ewes l 0" Moreover, Clarke 
and Cummins10 and Levine et al " demonstrated a consistent one-to-one relationship 
between pulses of LH-RH in portal blood and LH pulses in the peripheral circulation 
It may therefore be concluded that the analysis of LH pulse frequency in peripheral 
blood allows an indirect, although reliable assessment of episodic hypothalamic LH-
RH discharge. 
2 In vitro studies using pituitary glands or isolated pituitary cells In vivo animal studies 
using exogenous LH-RH have provided useful information regarding the underlying 
mechanisms by which pituitary gonadotropin release is regulated Pituitary response 
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patterns, however, may be influenced by the feedback action of gonadotropins and 
steroids upon the hypothalamic - pituitary axis. In vitro studies using a perifusion 
system of rat hcmipituitaries or dispersed rat pituitary cells demonstrated the signifi-
cance of the pulsatile nature of LH-RH secretion by showing that pituitary responsive-
ness to LH-RH can be maintained for a long period when LH-RH is given in pulses. I2'n 
If LH-RH is administered as a continuous infusion, the pituitary cells became desensit-
ized and gonadotropin secretion ceased as a result.14 Recently the influence of different 
LH-RH pulse parameters, such as frequency, pulse width and amplitude, on the mag-
nitude of LH output from perifused sheep15 and rat16 pituitary cells has been accurately 
defined. 
3. Exogenous LH-RH administration in animals with induced hypothalamic lesions. The 
importance of the pulsatile nature of LH-RH secretion was most convincingly demon-
strated by Knobil and his colleagues.17 They showed that in ovariectomized monkeys, 
in which endogenous LH-RH production had been abolished, continuous infusion 
of LH-RH was incapable of restoring sustained pituitary gonadotropin production. 
Pituitary function returned to normal, however, when the decapeptide was admin-
istered intermittently.18 Hence, the type rather than the dose of exogenous LH-RH 
appeared to be of primary importance for pituitary function. Later on it was found 
that varying the amplitude of LH-RH pulses has little regulatory effect whereas 
changes in the frequency of pulsatile LH-RH stimulation causes obvious changes in 
the levels of LH and FSH and the LH/FSH ratio. The optimal LH-RH pulse dose 
and frequency was defined for maximum pituitary stimulation in the monkey.19 Beside 
the practical implications, this work was of great theoretical significance in that it 
showed that the hypothalamic control of pituitary function in vivo must be intermit-
tent. Furthermore, these studies provided evidence that in the male monkey the nega-
tive feedback mechanism controlling gonadotropin release consists principally of inhi-
bition by testicular steroids (T) of pulsatile LH-RH release from the hypothalamus. 
In contrast, the pituitary is the principal site of action of ovarian steroids (Ei) in the 
female.20 A marked difference in the sensitivity of the male and female pituitary gland 
to LH-RH stimulation was also observed. 
Human studies of the hypothalamic - pituitary axis 
/. Patterns of endogenous LH levels in peripheral plasma. Animal studies'011 support 
the idea that the pattern of episodic changes of LH levels in peripheral plasma reflects 
the frequency of intermittent hypothalamic LH-RH release. The amplitude of LH 
pulses, however, depends not only upon the amount of LH-RH release but also on 
the pituitary sensitivity to LH-RH. Previous studies in human males measuring LH 
in peripheral blood samples obtained every 15 to 20 min for 6 to 24 h21·22 demonstrated 
an intermittent pattern of pituitary LH release with a pulse frequency of approximately 
60-120 min. On the basis of these results it was assumed that pulsatile hypothalamic 
LH-RH release also occurred at 60-120 min intervals. In view of the short half-life 
of LH, rapid hormone fluctuations may be disregarded when blood is sampled at 
relatively long intervals. Hence, it is conceivable that the accuracy of amplitude and 
frequency estimations increases as the number of samples per cycle increase. There 
are at present no generally accepted criteria for assessing the significance of a given 
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LH pulse. In the past, investigators based their conclusions merely on visual inspec­
tion. More recent interpretation is based on sophisticated computer programs de­
signed to detect pulsations and to discriminate between true biological signals and 
background noise. Winters and Troen23 recently reexamined pulsatile LH secretion 
in healty adult men and in patients with primary testicular failure. Blood samples 
were taken at 10 min intervals for 12 h (in accordance with Yates24 recommandation 
to sample at least 6 times the expected highest frequency of interest) and data were 
analyzed using the computerized 'cycle detection' program.25 The interval between 
LH pulses was calculated as 151 + 34 min (107 ± 8 min by visual inspection). But 
although the same schedule of blood control was used, Matsumoto and Bremner26 
failed to confirm these results. They calculated an LH pulse frequency of 95 + 9 min. 
Even more frequent venous sampling (at 1,2 and 4 min intervals) disclosed a significant 
number of otherwise unrecognized low amplitude LH pulses in normal men.27 The 
physiological significance of this rapid LH secretion is unknown at present, but proba­
bly reflects events at the hypothalamic-pituitary level which have no effect on gonadal 
function. Hence, the classic concept of 60 to 120 min intervals between pulsatile secre­
tions of hypothalamic LH-RH in men, based on estimates of LH pulse frequency 
in the early 70s, has been challenged by recent observations using a well-defined sched­
ule of blood control and more sophisticated methods of recognizing significant LH 
pulses. However, it must be stated that until now no general agreement exists on the 
actual interval between LH pulses in normal men. 
Recently much attention has been paid to preliminary data2 8 w suggesting a de­
creased number of LH pulses in patients with oligospermia and elevated FSH levels 
when compared with normal controls or Oligospermie men with normal FSH. A hy­
pothalamic defect was postulated on the basis of previous observations of Wildt et 
al.19 in the monkey where a decreased number of pulses during intermittent LH-RH 
administration did provoke changes in the LH/FSH ratios, since mean LH levels re­
mained unchanged and mean FSH levels rose. This phenomenon has recently been 
confirmed in hypogonadotropic men.31 However, changes in gonadal feedback activity 
may explain the described difference of pulsatile LH-RH release in Oligospermie men. 
This must definately be excluded in these patients because Matsumoto and Bremner26 
have conclusively demonstrated that Τ acts on the central nervous system and slows 
down the hypothalamic LH-RH release frequency. If this mechanism can be excluded, 
the observation of a decreased pulsatile LH-RH activity may prove to be of major 
clinical significance since pulsatile LH-RH therapy may very well be of value in this 
selected group of patients with idiopathic oligospermia. 
2. Patterns of pituitary secretion following exogenous LH-RH administration. By mea­
suring serum LH and FSH response patterns following LH-RH administration an 
attempt was made to obtain information how the pituitary responds under physiologi­
cal circumstances. In this respect most studies presented in this thesis deal with differ­
ent types of frequency-, and amplitude-modulated intermittent LH-RH administra­
tion to normal males. The large number of studies undertaken in this field commenced 
shortly after synthetic LH-RH became available in 1972 (for review sec chapter I). 
Conclusions from these studies should be drawn with caution since results are certainly 
infuenced by many other factors beside the administration of LH-RH. Such factors 
are the mutual interaction between endogenous and exogenous LH-RH, the differ-
47 
enees between bio- and immunoassayable hormone levels,32 " the use of different syn-
thetic LH-RH preparations with a different biological activity, and the possible feed-
back action of changing gonadotropic and steroid levels during the test period 
The hypothesis of multiple phases of pituitary LH release was first proposed in 
order to explain the observed biphasic response pattern for LH during continuous 
LH-RH infusion This biphasic pattern of pituitary secretion following LH-RH expo-
sure, either continuously or by repeated pulses, suggests the presence of two functional-
ly related pools The first pool represents pituitary sensitivity (LH storage), and the 
second pool is functionally related to reserve capacity (LH synthesis) (for further infor-
mation see chapter I) The magnitude of these two pools was regulated by ovarian 
steroids 34 The priming effect (augmentation of pituitary reserve capacity) was ob-
served in women only in the high-estrogen (late-follicular and mid-luteal) phases of 
the menstrual cycle ^ Under these conditions the initial pulse of LH-RH not only 
induces the release of pituitary LH but also sensiti7es the gonadotrops to subsequent 
stimulation It was thought that high estrogen levels, with their positive feedback ef-
fects, preferentially increased pituitary reserve capacity Moreover, this priming effect 
is considered an important factor in the series of events that causes the pre-ovulatory 
gonadotropin surge 3637 Following repeated, low-dose (10 ug), iv LH-RH administra-
tion in normal adult males, Lasley et al38 failed to demonstrate an increase of pituitary 
reserve capacity In other words, equal LH responses were measured following each 
subsequent pulse of LH-RH The estimation of reserve capacity may, however, require 
measurement of the quantitative release of pituitary LH as a function of time,3'' and 
by this means we were able to indirectly show that this self-priming effect does indeed 
exist in the male (see chapter II and III) The effect of continuous and pulsatile LH-RH 
administration on pituitary gonadotropin release was studied by comparing mean ser-
um levels of LH and FSH during the test period, instead of comparing the magnitude 
of gonadotropin release following each subsequent bolus dose of LH-RH These stud-
ies emphasize the functional significance of intermittent pituitary stimulation in men 
and show that the estrogen feedback action is not crucial to this priming effect In 
chapter III gonadotropin response patterns following pulsatile LH-RH administration 
at 20- and 60-min intervals are presented, the latter appeared to produce a more pro-
nounced priming effect Having established the superiority of the 60-min intervals 
the pulse dose was varied It was found that a bolus of 60 ug LH-RH resulted in 
a higher LH output than one of 20 ug However, it is likely that the intervals between 
LH-RH pulses in normal men will prove to be substantially longer than 60 mm We 
know from recent in vitro14 and in vivo19 animal studies that rapid LH-RH pulsations 
can also provoke pituitary desensitization For this reason it is essential to extend 
the above mentioned series of experiments (chapters II and III) using longer intervals 
between LH-RH pulses Intervals up to 150 mm may be indicated, in accordance with 
the assumed episodes of pulsatile endogenous LH-RH release in recent literature 23 
However, such studies are complicated Firstly the test period of 3 to 4 5 h must be 
increased considerably, because at least 3 consequetive boh must be given Secondly, 
the magnitude of the bolus will need to be modified Adherence to the established 
standard dose (60 ug/h) would mean that at an assumed frequency of 150 min, boh 
of 150 ug would be injected These will certainly produce pharmacological blood levels 
(see chapter VI) and carry a risk of partial pituitary desensitization 
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In contrast to most studies reported in the literature, some of the experiments in 
this thesis have been performed with an integrated blood sampling technique. This 
involves a constant slow withdrawal of blood to integrate plasma fluctuations of hor­
mone levels 39 This technique eliminates rapid changes in hormone levels and under­
estimates peak levels It is therefore incapable of measuring rapid hormone fluctua­
tions but is very suitable for the assessment of variation of hormone response patterns 
with time, and it was used for this purpose in experiments reported in chapters II 
and III 
Studies in the rat has demonstrated that LH-RH has a direct effect by itself on 
testicular androgen production and the number of LH receptors The administration 
of LH-RH to hypophysectomized rats reduced testicular LH receptors in direct pro­
portion to the dose ^ This direct action of LH-RH appeared to be mediated by specific 
LH-RH binding sites which have been identified in testicular Leydig cells 4I LH-RH 
directly increases the number of testicular receptors of this decapeptide, but the re­
sponse is modulated by gonadotropic hormones The inhibitory effect of LH-RH on 
Τ production is temporarily dissociated from the changes in LH-RH and LH receptor 
concentrations42 This suggests that the direct effect of LH-RH is a post-receptor event. 
Hsueh et a l 4 1 treated cultured rat testicular cells with hCG alone, and with the concom­
itant addition of LH-RH LH-RH reduces hCG-induced production of Τ, 17-OHP 
and androstenedion, without affecting progesterone and pregnenolone biosynthesis. 
These observations suggest that LH-RH inhibits the activity of 17alpha-hydroxylase 
and 17-20 desmelase enzymes, but has no effect on cholesterol side-chain cleavage 
enzymes, or other enzymes necessary to the steroidogenesis prior to pregnenolone 
formation. Since circulating concentrations of hypothalamic LH-RH are too low to 
have any significant direct gonadal effect, observations obtained from the study of 
Hsueh et a l 4 1 are further supportive evidence that an LH-RH-hke peptide is involved 
in hCG-mduced Leydig cell desensitization, since both 17alpha-hydroxylase and 
17-20 desmelase activity appears to be diminished after hCG administration M The 
reduction of testicular Τ secretion following LH-RH administration is a time-related 
event since it was discovered that Τ levels increased shortly after the exposure to 
LH-RH 45 ** In chapter IV of this thesis the experimental design was such that obtained 
LH levels were about equal regardless the frequency and amplitude of LH-RH admin­
istration. Therefore we can assume that Leydig cells were about equally stimulated 
by LH. The same total amount of LH-RH was given to healthy adult men both contin­
uously (1 ug/min, C(l, 1)) and intermittently (20 ug doses at 20-min intervals, P(20,20), 
and 60 ug doses at 60-min interval; P(60,60)) to determine whether different modes 
and doses of LH-RH exert different direct effects on testicular steroid biosynthesis. 
From a theoretical point of view, the choise of normal men (with an intact hypothalam­
ic - pituitary - gonadal axis) to investigate possible direct effects of LH-RH on testicu­
lar steroidogenesis may give rise to problems. The existence of endogenous LH-RH, 
however, may not be crucial since it seems unlikely that hypothalamic LH-RH is in­
volved in the local regulation of Leydig cell function To exclude the possible influence 
of changing gonadotropin levels as a bias in testing the direct gonadal effects of exoge­
nous LH-RH, patients with isolated gonadotropin deficiency may be more suitable. 
This condition, however, is rare. In the present study, the overall changes in gonadotro­
pin levels during the test period are of the same order of magnitude. A small, undetect-
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able difference in pituitary response may have occurred, particulary during the first 
30 min following commencement of LH-RH administration. An obvious difference 
in gonadal response was observed after comparing the three experiments performed. 
Mean serum Τ levels showed a rapid increase, followed by biphasic response patterns 
in the C(l,l) and P(20,20) experiments (for details see chapter IV). An explanation 
of the occurrence of a dip in Τ secretion at 60 min cannot be derived from the present 
data. Possible desensitization mechanisms which could underlie a biphasic Τ response, 
as described by Wang et al.47, are not involved since they occur more slowly, and 
significant E2 elevations have never been observed in the present study. In contrast, 
in the P(60,60) experiment a delayed, but persistent increase in Τ did occur, in the 
absence of the acute increase despite an overt elevation of mean serum LH levels. 
It is tempting to speculate that this differential Leydig cell response is brought about 
by a direct testicular effect of LH-RH itself. This effect must be dose-dependent since 
the higher concentration of LH-RH shortly after commencing administration in the 
P(60,60) experiment may inhibit Τ synthesis, whereas the lower serum levels in the 
C(l,l) and P(20,20) experiments did not. This observation contrasts with data in the 
literature which show changes in levels of Τ secretion to be a time-related, instead 
of a dose-related, event.45·4* The absence of inhibitory effects on Τ synthesis following 
the second and third LH-RH bolus injection in the P(60,60) experiment can be ex­
plained by the occupation of Leydig cell LH-RH receptors at the time of subsequent 
bolus injections. This hypothesis is supported by data from the literature on pharma­
cokinetics of LH-RH receptors (for review see Clayton and Catt48). It was shown that 
the dissociation of LH-RH-receptor complexes consisted of a two-phase curve with 
a rapid initial phase and a slower second phase (half-life approximately 80 min). Since 
17-OHP also failed to increase shortly after starting LH-RH administration in the 
P(60,60) experiment, the lack of an initial Τ increase would seem to be due to an 
induced block early in the steroidogenic pathway (17alpha-hydroxylase enzyme) or 
possibly at the LH receptor level of Leydig cells. This observation is supported in 
the literature by data on the exact site of action of LH-RH in rat Leydig cells in vitro.43 
In conclusion, in vitro studies in the rat have not yet elucidated the mechanism by 
which LH-RH directly regulates testicular function. It may very well be that its action 
on Leydig cells is either direct modulation of steroidogenesis or modification of their 
sensitivity to LH stimulation. All the above mentioned studies in the literature were 
performed in the rat and conclusions derived from such studies may not be valid for 
higher primates like men. For instance, Clayton and Huhtanimie49 were unable to 
demonstrate LH-RH receptors in human gonadal tissue although their existence in 
the rat has been reported by several authors.41·50 Moreover, in the human testis the 
most important steroidogenic pathway appears to be the Δ5, whereas the A4-palhway 
is more important for Τ synthesis in the rat.51 Hence, in men pregnenolone, 17-OH-
pregnenolone and dihydro-epiandosterone should be determined instead of 
A4-pathway precursors (such as progesterone, 17-OHP and androstenedion) to obtain 
appropriate information on Τ biosynthetic precursors. If direct testicular effects of 
LH-RH in the human is as suggested in chapter IV, and if this mechanism is operative 
under normal conditions, the first aim of investigation in this field must be to demon­
strate LH-RH like activity in human gonadal tissue. 
The study of LH-RH pharmacokinetics following its exogenous administration (us-
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ing a momentaneous blood sampling technique to disclose rapid hormone fluctua­
tions), as shown in chapter VI, sheds new light on conclusions drawn in previous 
chapters. From this study it appears that the administration of 20 ug bolus doses 
at 20-min intervals leafs insufficient time for the serum LH-RH levels to return to 
baseline, and therefore if administration at this rate is continued dose accumulation 
will occur. Hence, the conclusions drawn in chapter II about the observed difference 
between LH responses when comparing continuous and intermittent LH-RH adminis­
tration at 20 min intervals and 20 ug bolus doses only to be caused by changing LH-RH 
levels in the later administration type, seems only partly justified. A continuous in­
crease of LH-RH serum levels will occur with a superimposed increase following each 
subsequent bolus administration and the gonadotrops will therefore be stimulated 
continuously as well as intermittently. We have not measured the profile of LH-RH 
plasma levels following a 60 ug bolus dose. It is likely, however, that the pulsatile 
LH-RH administration using 60 ug bolus doses at 60-min intervals (see chapter III) 
will cause slowly accumulating LH-RH serum levels as well. As is shown in perifusion 
studies using sheep15 and rat16 pituitary cells, the pulsatile delivery of large doses of 
LH-RH may also cause pituitary desensitization. This proces could also have occurred 
to some extend in our own studies although desensitization occurs more slowly in 
vitro (approximately 4h). For this reason, the observed differences in LH response 
patterns may be even more pronounced when lower doses of LH-RH are used. 
Increasing knowledge regarding endocrine mechanisms regulating pituitary func­
tion has resulted in a widespread contemporary use of pulsatile LH-RH therapy in 
men and women suffering from hypogonadotropic hypogonadism."55 The recent 
availability in our laboratory of a reliable RIA technique able to quantify plasma 
LH-RH levels gave us the opportunity to study the most appropriate dose and route 
of administration in pulsatile LH-RH therapy. Data obtained from this study, using 
a 5 and 20 ug bolus dose given either iv. or sc. (chapter VI), clearly showed the low 
(5 ug) dose and the iv. route to be preferable. The profile of LH-RH serum levels 
following the iv. route of administration more closely resembles the assumed pattern 
of endogenous hypothalamic LH-RH secretion, with much sharper and well defined, 
LH-RH pulses. In this study the amount of LH output did not seem to be much in­
fluenced by the amplitude of LH-RH pulses in the blood since 5 and 20 ug iv. LH-RH 
administration appears equally effective in promoting adequate pituitary LH release. 
This is in agreement with in vitro observations using sheep pituitary cells15 in which 
it was shown that increasing the LH-RH pulse amplitude above a certain threshold 
level has little additional effect on LH output. However, these data contradict the 
results presented in chapter III, where a difference in LH response patterns was ob­
served between pulsatile LH-RH administration using 20 and 60 ug doses at 60-min 
intervals. In addition, it would be of special interest to know whether bolus doses 
of LH-RH even lower than 5 ug (for instance 2.5 ug and 1 ug) would cause a significant 
increase in LH-RH plasma levels and subsequent adequate pituitary LH release. 
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SUMMARY 
Chapter I (introduction). The literature of possible minor endocrine abnormalities 
in men presenting with idiopathic oligospermia is reviewed. There is increasing evi-
dence that, beside deminished seminiferous tubule function, defects of Leydig cell ster-
oidogenesis may also be involved. The need for detailed and accurate data on the 
hormonal mechanisms which regulate normal pituitary and testicular function, is 
stressed. Such data are crucial to further investigation of possible hormone lesions 
accompanying idiopathic oligospermia. Furthermore, the present state of knowledge 
of male reproductive endocrinology is briefly reviewed. Special attention is paid to 
studies in the human using exogenous LH-RH. 
All studies presented in this thesis deal with different types of exogenous LH-RH 
administration in the adult male, in an attempt to study some aspects of pituitary 
and gonadal function under normal circumstances. Pituitary gonadotropin and some-
times testicular steroid response patterns were determined and analyzed following in-
termittent LH-RH exposure at different pulse-doses, pulse-intervals and following dif-
ferent routes of administration. 
Chapter II deals with pituitary gonadotropin response patterns following 2 types of 
iv. LH-RH administration in 14 healthy adult men. The same total amount of LH-RH 
(60 ug/h) was administered continuously (1 ug/min; C(l,l)) and in increments of 20 
ug at 20 min intervals (P(20,20)). Serum LH and FSH levels were determined by means 
of an integrated blood sampling technique. During continuous LH-RH infusion serum 
LH levels increased rapidly for the first 45 min and thereafter remained constant. 
During pulsatile LH-RH administration LH levels also increased rapidly, but were 
later followed by a further increase from approximately 105 min until the end of the 
test period. Serum LH levels, measured throughout the 4.5 h test period and after 
correction for the observed difference in baseline values, were significantly higher 
(P < 10 5) during pulsatile than during continuous LH-RH administration. FSH levels 
revealed a gradual, but progressive increase, without significant difference, in both 
experiments. 
Chapter III is an extension of the investigation described in chapter II. Two further 
incremental LH-RH administration patterns, with 60 min pulse intervals, were added. 
One used the same (60 ug/h) total amount of LH-RH (P(60,60)) and the other a lower 
(20 ug) bolus dose (P(20,60)). Data obtained from this study confirmed the existence 
of a greater LH response during pulsatile LH-RH administration. The largest LH 
output was obtained during pulsatile administration at 60 min intervals. The self-po-
tentiating (priming) effect of intermittent LH-RH administration for pituitary LH 
output was indirectly demonstrated in this way. This phenomenon has been described 
in studies in the female (see chapter I and VII for review). This indicates that repeated 
pituitary stimulation, by equal doses of LH-RH, causes increasing pituitary sensitivity 
to subsequent LH-RH administration. The increased sensitivity represents novo-syn-
thesis while the initial response is indicative of the release of stored LH only. In addi-
tion, it appeared that the magnitude of LH release was also related to the amount 
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of LH-RH given as a bolus dose. Again no mutual difference was observed for FSH 
responses between different groups. 
The study presented in chapter IV concerns changes of testicular steroidogenesis dur­
ing 3 modes of (continuous and pulsatile) LH-RH administration in equal dosages 
(C(l,l), P(20,20) and P(60,60)) in the same group of 14 healthy male volunteers as 
described in the preceeding chapters. Serum T, Ej and 17-OHP levels were determined 
in peripheral plasma by means of an integrated blood sampling technique. This investi­
gation was designed firstly to study short-term Leydig cell responses following LH-RH 
mediated elevations in gonadotropin serum levels and secondly to study possible mo­
dulating effects of different modes and doses of LH-RH acting directly on gonadotro-
pin-induced steroid biosynthesis. All applied modes of LH-RH administration caused 
gonadotropin release of a comparable magnitude (3-4 fold for LH and 1.7-2 fold 
for FSH). A similar overall Τ response was observed throughout the 3 h duration 
of the various experiments. The patterns of the Τ response, however, clearly differed 
one from another with a rapid increase and biphasic response during the C( 1,1) and 
P(20,20) LH-RH administration, and a delayed but persistent increase in the P(60,60) 
experiment. It was concluded from this study that Leydig cell Τ synthesis occurs very 
rapidly. Moreover, LH-RH seems to modulate testicular steroid response directly. 
Chapter V describes the effects of long-term, pulsatile, low dose (5 and 20 ug), sc. 
LH-RH administration in 4 men presenting with idiopathic oligospermia. In view of 
the possibility that this group of men may, at least in part, include individuals with 
minor abnormalities involving the pituitary - testicular axis (see chapter I for discus­
sion) and the lack of criteria of selection for these patients, we thought it useful to 
investigate the influence of pulsatile LH-RH administration on hormonal and sperm 
parameters in this group. LH-RH was administered in a regimen which had proved 
successful in hypogonadotropic men and women. During and following the LH-RH 
treatment period, however, no changes were observed either in hormonal or in sperm 
parameters. Possible underlying causes of this failure of therapeutic response are exten­
sively discussed. Such mechanisms are: 1. heterogenous causes of impaired spermato­
genesis in idiopathic oligospermia, 2. insufficient LH-RH dosage schedule, 3. interfer­
ence between administered and endogenous LH-RH. 
In chapter VI some aspects of pharmacokinetics of LH-RH administration are studied. 
The purpose of the study was to resolve some of the existing controversy in the litera­
ture regarding the most appropriate dose and route of increment of administration 
of LH-RH in therapeutic regimens. LH-RH was administered at different (5 and 20 
ug) bolus doses, given either iv. or sc. to 20 healty men. The pattern of LH-RH and 
the corresponding pituitary gonadotropin release was determined by means of mo-
mentaneous blood sampling at frequent time intervals. Strong evidence was adduced 
that the iv. route is preferable since LH-RH pulses in peripheral blood appeared much 
sharper and well defined. It seems probable, therefore, that the in vivo pattern of 
hypothalamic LH-RH discharge resembles this closely. Moreover, the risk of dose 
accumulation and subsequent pituitary desensitization during pulsatile LH-RH thera­
py is considerably reduced by iv. administration, due to the short half-life of serum 
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LH-RH levels The 5 ug dose seems to be as effective in promoting adequate pituitary 
LH release, as the 20 ug dose Low-dose, iv administration is recommended in thera-
peutic regimens using pulsatile LH-RH administration 
Chapter VII (discussion) In this chapter an attempt is made to place the line of thought 
pursued in the present thesis (i e the influence of LH-RH on reproductive function 
in the human male) in a wider perspective Animal and human studies are classified 
systematically according to the light they throw upon the way in which LH-RH regu-
lates pituitary and testicular function Special attention is given to work on the direct 
estimation of LH-RH, indirect methods by which LH-RH levels are derived from 
LH estimations in peripheral blood, and studies of pituitary function after administra-
tion of exogenous LH-RH 
Several points such as the magnitude of and interval between increments in the 
intermittent administration of LH-RH (chapter II and III) and the possible direct 
action of LH-RH on testicular steroid synthesis (chapter IV) are discussed in more 
detail 
Some suggestions are made for possible future lines of investigation, arising from 
the recent literature as well as our own research on the pharmacokinetis of LH-RH 
administration (chapter VI) 
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SAMENVATTING 
In hoofdstuk I wordt een overzicht gepresenteerd van literatuur gegevens betreffende 
het mogelijk voorkomen van hormonale afwijkingen bij mannen met een idiopathische 
Oligospermie Steeds meer aanwijzingen worden gevonden die pleiten voor het bestaan 
van een gestoorde steroid synthese in de Leydig cel naast een verminderde functie 
van de tubulus semmiferus Speciaal wordt de noodzaak benadrukt van een nauwkeu-
rige kennis van endocriene mechanismen die de hypofyse en testis functie onder norma-
le omstandigheden reguleren Deze kennis is van cruciaal belang voor de verdere bestu-
dering van mogelijke hormonale afwijkingen die samen gaan met idiopathische Oligo-
spermie Een kort overzicht wordt gegeven van de huidige inzichten omtrent de repro-
ductieve endocrinologie bij de man waarbij vooral aandacht wordt besteed aan studies 
betreffende LH-RH toediening 
Alle studies die in dit proefschrift worden beschreven handelen over verschillende 
wijzen van exogene LH-RH toediening bij volwassen mannen, in een poging om enige 
aspecten van hypofyse en testis functie onder normale omstandigheden te bestuderen 
De hypofysaire gonadotrofme en soms eveneens de testiculaire steroid respons patro-
nen werden bepaald en geanalyseerd na een intermitterende blootstelling aan LH-RH, 
in verschillende puls-doses, puls-intervallen en na verschillende toedieningswij/en 
In hoofdstuk II worden de hypofysaire gonadotrofine respons patronen besproken 
na 2 typen van iv LH-RH toediening bi] 14 gezonde, volwassen mannen Een gelijke 
totale hoeveelheid LH-RH (60 ug/h) werd toegediend, zowel continue (1 ug/min, 
C(l,l)) als intermitterend (20 ug doses en 20 min interval, P(20,20)) Serum LH en 
FSH spiegels werden bepaald met gebruik making van een techniek voor continue 
(geïntegreerde) bloedafname Tijdens continue LH-RH toediening werd een snelle LH 
stijging waargenomen gedurende de eerste 45 min, met daarna een plateau Tijdens 
intermitterende LH-RH toediening werd eveneens een snelle LH stijging gezien, ge-
volgd door een verdere stijging daarna vanaf circa 105 min tot aan het eind van de 
testperiode Serum LH spiegels, gemeten gedurende de 4 5 h testperiode en na correctie 
voor de verschillen in basale waarden, waren significant hoger (P < 10 5) tijdens inter-
mitterende dan tijdens continue LH-RH toediening FSH spiegels vertoonden een ge-
leidelijk progressieve stijging, zonder een duidelijk verschil tussen de beide experimen-
ten 
Hoofdstuk III is een uitbreiding van de studie beschreven in hoofdstuk II Twee inter-
mitterende LH-RH toedienmgswi)zen, met een puls interval van 60 min, werden toe-
gevoegd Een met dezelfde (60 ug'h) totale hoeveelheid LH-RH (P(60,60)) en de andere 
toedieningswijze met een lagere (20 ug) dosis (P(20,60)) Gegevens die middels deze 
studie werden verkregen bevestigden het bestaan van een toegenomen LH respons 
na intermitterende LH-RH toediening De grootste LH afgifte werd verkregen na 
intermitterende toediening met 60 min interval Op een indirecte wijze werd hiermee 
het zelf-potentierend (of priming) effect van intermitterende LH-RH toediening voor 
de hypofysaire LH afgifte aangetoond Dit fenomeen is bij de vrouw uitvoerig in de 
literatuur beschreven (zie hiervoor hoofdstuk I en VII) Het betekent dat een herhaalde 
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hypofyse stimulering, met steeds gelijke doses LH-RH, een toename van hypofysaire 
gevoeligheid voor een daaropvolgende LH-RH toediening geeft. Deze toegenomen 
gevoeligheid geeft een nieuwe synthese weer, terwijl de initiële respons duidt op de 
afgifte van opgeslagen LH. Tevens bleek dat de mate van LH afgifte eveneens afhanke-
lijk is van de hoeveelheid LH-RH als bolus toegediend. Ook nu werd voor FSH geen 
onderling respons verschil waargenomen. 
De studie, die wordt gepresenteerd in hoofdstuk IV, betreft veranderingen in de testicu-
laire steroid synthese tijdens 3 verschillende LH-RH toedieningswijzen (continue en 
intermitterend), in gelijke doses (C(l,l), P(20,20) en P(60,60)). Het onderzoek werd 
verricht bij een zelfde groep van 14 gezonde volwassen mannen die ook in de vorige 
hoofdstukken beschreven werd. Serum spiegels van T, Ej en 17-OHP werden bepaald 
in perifeer bloed, eveneens met gebruik making van een techniek voor continue bloed-
afname. Het doel van de studie was om de korte termijn respons van de Leydig cel 
op een LH-RH geïnduceerde stijging van gonadotrofine spiegels te bestuderen, waarbij 
de mogelijk modulerende effecten van verschillende wijzen van LH-RH toediening 
rechtstreeks op de gonadotrofine geïnduceerde steroid synthese eveneens werden beke-
ken. Het toegediend LH-RH gaf in alle gevallen een gonadotrofine afgifte van ver-
gelijkbare grootte (3-4 voudige stijging voor LH en 1.7-2 voudige stijging voor FSH). 
De totale Τ afgifte gedurende de gehele 3 h testperiode was gelijk in de verschillende 
experimenten. Het patroon van de Τ respons was echter duidelijk verschillend, met 
een snelle stijging en bifasische respons tijdens de C( 1,1) en P(20,20) LH-RH toedie­
ning en een vertraagde maar aanhoudende stijging tijdens het P(60,60) experiment. 
Uit deze studie kan geconcludeerd worden dat Leydig cel Τ synthese zeer snel kan 
geschieden. Voorts werden aanwijzingen gevonden voor een rechtstreeks modulerende 
invloed van LH-RH op de testiculaire steroid respons. 
Hoofdstuk V beschrijft het effect van een langdurige, intermitterende, laag gedoseerde 
(5 en 20 ug), se. LH-RH toediening bij 4 mannen met een idiopathische Oligospermie. 
Aannemende dat deze groep mannen, in ieder geval voor een deel, personen bevat 
met geringe afwijkingen in de hypofyse - testis as (zie hoofdstuk I voor discussie) 
en het ontbreken van criteria om deze patiënten te selecteren, achtten wij het zinvol 
om de invloed van intermitterende LH-RH therapie op hormonale en sperma parame-
ters in deze groep na te gaan. Het LH-RH werd toegediend op een wijze die reeds 
succesvol was gebleken bij hypogonadotrope mannen en vrouwen. Echter, zowel tij-
dens als na LH-RH behandeling werden geen veranderingen waargenomen in hormo-
nale evenals sperma parameters. Mogelijke oorzaken die ten grondslag zouden kunnen 
liggen aan het uitblijven van een therapeutisch resultaat worden uitvoerig bediscus-
sieerd. Zulke factoren zijn; 1. de grote heterogeniciteit in oorzaken van verminderde 
Spermatogenese bij idiopathische Oligospermie, 2. ineffectiviteit van het toegepaste 
LH-RH doseringsschema, 3. interactie tussen endogeen en toegediend LH-RH. 
In hoofdstuk VI worden enige farmacokinetische aspecten van LH-RH toediening 
bestudeerd. De studie had tot doel om enige bestaande controversen in de literatuur, 
betreffende de meest geschikte dosis en toedieningswijze van exogeen LH-RH bij inter-
mitterende therapie, op te lossen. LH-RH werd toegediend in verschillende (5 en 20 
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ug) bolus doses, zowel iv als se. aan 20 gezonde mannen Het patroon van LH-RH, 
alsmede de corresponderende hypofysaire gonadotrofine afgifte werd bepaald met ge-
bruik making van frequente bloedcontrole Duidelijk werd hierbij aangetoond dat 
de iv toedieningsweg te prefereren is aangezien veel scherpere en duidelijk omschreven 
LH-RH pulsen in perifeer bloed werden waargenomen Het lijkt waarschijnlijk dat 
het patroon van hypothalame LH-RH afgifte in vivo hierop sterk gelijkt Voorts wordt 
het risico van dosis accumulatie en daaropvolgende hypofyse desensitizatie bij inter-
mitterende LH-RH behandeling sterk gereduceerd door iv toediening ten gevolge van 
de korte halfwaarde tijd van LH-RH spiegels De 5 ug dosis lijkt, ten opzichte van 
20 ug, even effectief in het veroorzaken van een adquate hypofysaire LH afgifte De 
laag-gedoseerde, iv toediening wordt derhalve aanbevolen in therapeutische regimes, 
waarbij intermitterend LH-RH wordt toegepast 
In het discussie hoofdstuk (VII) wordt getracht om de in dit proefschrift besproken 
onderzoekslijn omtrent de invloed van LH-RH op de reproductieve functie bij de man, 
in een breder perspectief te plaatsen Studies bij mens en dier worden systematisch 
ingedeeld al naar gelang de bestudering van verschillende aspecten van de wijze waarop 
het LH-RH het functioneren van hypofyse en testis reguleert Hierbij wordt speciaal 
ingegaan op studies omtrent de rechtstreekse meting van LH-RH, de indirecte wijze 
waarop informatie over LH-RH wordt verkregen door middel van LH metingen in 
het perifeer bloed en studies betreffende de hypofyse functie na exogene LH-RH toe-
diening 
Enkele discussie punten worden becommentarieerd, zoals de gekozen puls dosis en 
het puls interval bij intermitterende LH-RH toediening (hoofdstuk II en III) en de 
mogelijk rechtstreekse werking van het LH-RH op de steroid synthese in de testis 
(hoofdstuk IV) 
Aan de hand van gegevens uit de recente literatuur en uit on/e studie omtrent de 
farmacokinetische aspecten van LH-RH toediening (hoofdstuk VI) worden enige mo-
gelijkheden voor verder onderzoek aangegeven 
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EENVOUDIG GEZEGD 
Idiopathische Oligospermie bij de man wordt gedefinieerd als een verminderde zaad­
productie zonder een duidelijk aanwijsbare oorzaak. In de recente literatuur worden 
aanwijzingen gevonden die pleiten voor het bestaan van hormonale afwijkingen m 
deze groep Om te komen tot een betere interpretatie van deze veranderingen moet 
eerst de hormonale situatie onder normale omstandigheden nauwkeurig worden gede­
termineerd Dit proefschrift doet een poging daartoe Bij normale mannen werd de 
reactie van hypofyse en testis bestudeerd na toediening van LH-RH (een 'releasing7 
hormoon uit de hypothalamus, dat intermitterend in de portale circulatie wordt af­
gegeven en de hypofyse aanzet tot de afgifte van gonadotrofmes) Nauwkeurig werd 
nagegaan wat de invloed van verschillende wijzen van iv LH-RH toediening is (zowel 
continue als intermitterend) op de hypofysaire afgifte van LH en FSH gedurende een 
bepaalde tijd en op de synthese van Τ door de Leydig cellen gelegen in de testis Ook 
werden verschillende doses LH-RH gegeven, zowel iv als se , om na te gaan wat hierna 
het verloop is van de LH-RH spiegels in het bloed en te registreren hoe de hypofyse 
op deze verschillende signalen reageert Hierdoor kon duidelijk worden aangegeven 
welke wijze van LH-RH toediening de voorkeur verdient, in situaties waarbij LH-RH 
behandeling is geïndiceerd Voorts kregen 4 mannen met idiopathische Oligospermie 
een proefbehandelmg met intermitterend LH-RH om na te gaan wat de invloed van 
deze toediening is op de hormonale parameters en de zaad kwaliteit 
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Stellingen behorende bij het proefschrift 
LH-RH and reproductive function in the human male 
B.C.J. M.Fauser 
I 
Ook bij de man is, naast de dosis, vooral de wijze van LH-RH toediening van invloed 
op de hypofysaire afgifte van LH. 
π 
Voor de selektie van mannen met een idiopathische Oligozoospermie, die in aanmer­
king komen voor een behandeling met intermitterend LH-RH, zijn onvoldoende crite­
ria voorhanden. 
III 
Bij intermitterende LH-RH behandeling verdienen de intraveneuze wijze van toedie­
ning en een lage puls-dosis de voorkeur. 
IV 
De vaak geuitte veronderstelling dat een veranderd patroon van LH-RH afgifte door 
de hypothalamus ten grondslag ligt aan het polycysteus ovarieel syndroom, is nooit 
overtuigend aangetoond. 
(Molloy et al., Br J Obstet Gynaecol 91:457, 1984) 
ν 
Bij hormonale screening van vrouwen met verminderde vruchtbaarheid is de bepaling 
van dihydrocpiandosteronsulfaat serum spiegels van minstens even grote betekenis 
als de bepaling van testosteron. 
(Hoffman and Lobo, Fértil Steril 41: 196,1985) 
vi 
Het is niet te verwachten dat de doorbraak van de behandeling van mannen met ver-
minderde vruchtbaarheid zal komen voordat, op cellulair niveau, de functie en interak-
tie van Leydig- en Sertoli-cellen nauwkeuriger is gedetermineerd. 
VII 
Vanuit het oogpunt van kwaliteit, efficiëntie en werkplezier is het verstandig om in 
de Nederlandse gezondheidszorg meer ruimte te bieden aan commercieel beheerde 
centra, mits hierop een goede controle bestaat. 
Ш 
Bij het zoeken naar oorzaken van eclamptogene gestóse, verdient de mogelijkheid van 
een partiële obstructie van de rechter ureter meer aandacht. 
(К. С M. Fauser, 4e Wereld Congres 'Hypertension and Pregnancy', Amsterdam, 
juni 1984, Abstract p. 5) 
IX 
Het ontbreken van een visie bij de toepassing van moderne technologie kan leiden 
tot absurde situaties. Dit wordt duidelijk gedemonstreerd door de mogelijkheid om 
vanaf 1986, in Amerika, as van gecremeerde mensen in een baan om de aarde te bren­
gen. 
χ 
Er werd vaak beweerd dat de patiënt onvoldoende tot zijn recht kwam binnen de 
arts-patiënt relatie. Dit geldt tegenwoordig ook frequent voor de arts. 
XI 
Promotiekosten kunnen nu hooguit leiden tot een fiscale aftrekpost. Ook deze wijze 
van wetenschapsfinanciering zou vereenvoudigd dienen te worden. 
XII 
Ook een mannelijke gynaecoloog kan goed bevallen. 


